Derek M. Yellon

Q: What Schools Are Affiliated With Derek M. Yellon

Derek M. Yellon is affiliated with the following schools: University of Leicester, University of California, Berkeley, University of Cape Town, California Institute of Technology, University College London, Stanford University

Derek M. Yellon's AcademicInfluence.com Rankings

Derek M. Yellon

Physics

#2065

World Rank

#3105

Historical Rank

physics Degrees

Download Badge

Physics

Derek M. Yellon's Degrees

Bachelors Physics University of California, Berkeley
PhD Physics Stanford University

Why Is Derek M. Yellon Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Derek Miles Yellon is a South African-British researcher in the biomedical sciences, known for his work in cardiovascular medicine. He is a professor of molecular and cellular cardiology at University College London, and is director of the Hatter Cardiovascular Institute at University College London Hospitals and Medical School.

(See a Problem?)

Derek M. Yellon's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Myocardial reperfusion injury. (2007) (1900)
Myocardial ischemia-reperfusion injury: a neglected therapeutic target. (2013) (1655)
The Lambeth Conventions: guidelines for the study of arrhythmias in ischaemia infarction, and reperfusion. (1988) (1128)
Cardiac stress protein elevation 24 hours after brief ischemia or heat stress is associated with resistance to myocardial infarction. (1993) (1111)
Preconditioning the myocardium: from cellular physiology to clinical cardiology. (2003) (1105)
New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. (2004) (1066)
Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury. (1995) (912)
Inhibiting Mitochondrial Fission Protects the Heart Against Ischemia/Reperfusion Injury (2010) (837)
Preconditioning the human myocardium (1993) (754)
Postconditioning: A Form of “Modified Reperfusion” Protects the Myocardium by Activating the Phosphatidylinositol 3-Kinase–Akt Pathway (2004) (709)
Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial (2007) (675)
Inhibiting mitochondrial permeability transition pore opening: a new paradigm for myocardial preconditioning? (2002) (631)
De novo cardiomyocytes from within the activated adult heart after injury (2011) (624)
Remote Ischemic Preconditioning and Outcomes of Cardiac Surgery. (2015) (616)
Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury. (2005) (610)
Anthracycline Chemotherapy and Cardiotoxicity (2017) (582)
Cardiovascular remodelling in coronary artery disease and heart failure (2014) (580)
Myocardial Protection by Insulin at Reperfusion Requires Early Administration and Is Mediated via Akt and p70s6 Kinase Cell-Survival Signaling (2001) (572)
Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection (2007) (546)
Species variation in the coronary collateral circulation during regional myocardial ischaemia: a critical determinant of the rate of evolution and extent of myocardial infarction. (1987) (545)
Ischemic preconditioning protects by activating prosurvival kinases at reperfusion. (2005) (541)
Remote ischaemic preconditioning: underlying mechanisms and clinical application. (2008) (521)
Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. (2010) (518)
Survival kinases in ischemic preconditioning and postconditioning. (2006) (506)
The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning. (2005) (476)
Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. (2003) (457)
Retrograde heart perfusion: the Langendorff technique of isolated heart perfusion. (2011) (416)
Ischaemic conditioning and reperfusion injury (2016) (398)
Plasma exosomes protect the myocardium from ischemia-reperfusion injury. (2015) (396)
Multitarget Strategies to Reduce Myocardial Ischemia/Reperfusion Injury: JACC Review Topic of the Week. (2019) (395)
Protein kinase C. Its role in ischemic preconditioning in the rat. (1994) (393)
Myocardial reperfusion injury: looking beyond primary PCI. (2013) (344)
The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. (2003) (334)
Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. (1995) (333)
Necrostatin: A Potentially Novel Cardioprotective Agent? (2007) (307)
Transient Mitochondrial Permeability Transition Pore Opening Mediates Preconditioning-Induced Protection (2004) (303)
Preconditioning and postconditioning: underlying mechanisms and clinical application. (2009) (301)
Preconditioning and postconditioning: united at reperfusion. (2007) (299)
Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway. (2003) (296)
Practical guidelines for rigor and reproducibility in preclinical and clinical studies on cardioprotection (2018) (293)
Preconditioning and postconditioning: the essential role of the mitochondrial permeability transition pore. (2007) (291)
Remote ischemic conditioning. (2015) (285)
Adenosine Receptor Involvement in a Delayed Phase of Myocardial Protection 24 Hours After Ischemic Preconditioning (1994) (284)
Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel–Dependent Mechanism (2007) (283)
Ischaemic preconditioning: present position and future directions. (1998) (283)
Preconditioning protects by inhibiting the mitochondrial permeability transition. (2004) (277)
A "second window of protection" or delayed preconditioning phenomenon: future horizons for myocardial protection? (1995) (277)
Preconditioning the diabetic heart: the importance of Akt phosphorylation. (2005) (276)
The mitochondrial permeability transition pore as a target for preconditioning and postconditioning (2009) (272)
Microvesicles and exosomes: new players in metabolic and cardiovascular disease. (2016) (271)
Ischaemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass surgery. (1997) (265)
Ischaemic conditioning and targeting reperfusion injury: a 30 year voyage of discovery (2016) (264)
Remote ischaemic preconditioning reduces myocardial injury in patients undergoing cardiac surgery with cold-blood cardioplegia: a randomised controlled trial (2009) (263)
Targeting reperfusion injury in patients with ST-segment elevation myocardial infarction: trials and tribulations (2016) (248)
Translating novel strategies for cardioprotection: the Hatter Workshop Recommendations (2010) (246)
Urocortin Protects against Ischemic and Reperfusion Injury via a MAPK-dependent Pathway* (2000) (242)
The neural and humoral pathways in remote limb ischemic preconditioning (2010) (241)
Translating cardioprotection for patient benefit: position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. (2013) (236)
The therapeutic potential of ischemic conditioning: an update (2011) (236)
New horizons in cardioprotection: recommendations from the 2010 National Heart, Lung, and Blood Institute Workshop. (2011) (226)
Remote ischemic conditioning reduces myocardial infarct size and edema in patients with ST-segment elevation myocardial infarction. (2015) (224)
Signalling via the reperfusion injury signalling kinase (RISK) pathway links closure of the mitochondrial permeability transition pore to cardioprotection. (2006) (219)
Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury (2000) (213)
Mitochondrial K(ATP) channels: role in cardioprotection. (2002) (206)
Comparison of small extracellular vesicles isolated from plasma by ultracentrifugation or size-exclusion chromatography: yield, purity and functional potential (2018) (200)
Reperfusion injury salvage kinase and survivor activating factor enhancement prosurvival signaling pathways in ischemic postconditioning: two sides of the same coin. (2011) (200)
Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening (2008) (199)
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart (2017) (197)
Bradykinin limits infarction when administered as an adjunct to reperfusion in mouse heart: the role of PI3K, Akt and eNOS. (2003) (197)
PI3 kinase and not p42/p44 appears to be implicated in the protection conferred by ischemic preconditioning. (2002) (196)
The protective role of heat stress in the ischaemic and reperfused rabbit myocardium. (1992) (196)
Cross-talk between the survival kinases during early reperfusion: its contribution to ischemic preconditioning. (2004) (195)
Does ischemic preconditioning occur in patients? (1994) (195)
Effect of remote ischaemic conditioning on clinical outcomes in patients with acute myocardial infarction (CONDI-2/ERIC-PPCI): a single-blind randomised controlled trial (2019) (189)
Insulin administered at reoxygenation exerts a cardioprotective effect in myocytes by a possible anti-apoptotic mechanism. (2000) (188)
B-type natriuretic peptide limits infarct size in rat isolated hearts via KATP channel opening. (2003) (187)
Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemiareperfusion injury (2007) (186)
Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo (2005) (185)
Effect of aging on the ability of preconditioning to protect rat hearts from ischemia-reperfusion injury. (2001) (183)
Reducing myocardial infarct size: challenges and future opportunities (2015) (179)
Xanthine oxidase: a critical mediator of myocardial injury during ischemia and reperfusion? (1986) (178)
Effect of remote ischaemic preconditioning on clinical outcomes in patients undergoing cardiac bypass surgery: a randomised controlled clinical trial (2014) (175)
Peri-procedural myocardial injury during percutaneous coronary intervention: an important target for cardioprotection. (2011) (174)
Urocortin protects the heart from reperfusion injury via upregulation of p42/p44 MAPK signaling pathway. (2002) (174)
Statins and cardioprotection--more than just lipid lowering? (2009) (172)
Involvement of protein kinase C in the delayed cytoprotection following sublethal ischaemia in rabbit myocardium (1995) (171)
Inhibition of nitric oxide limits infarct size in the in situ rabbit heart. (1993) (171)
Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. (2000) (171)
Preconditioning in isolated superfused human muscle. (1995) (169)
Mitochondrial permeability transition pore as a target for cardioprotection in the human heart. (2005) (169)
Inhibition of nitric oxide synthesis reduces infarct size by an adenosine-dependent mechanism. (1995) (169)
Characterisation of the infarct-limiting effect of delayed preconditioning: timecourse and dose-dependency studies in rabbit myocardium (1997) (166)
The Cardioprotective Effect of Necrostatin Requires the Cyclophilin-D Component of the Mitochondrial Permeability Transition Pore (2007) (166)
Failure to protect the myocardium against ischemia/reperfusion injury after chronic atorvastatin treatment is recaptured by acute atorvastatin treatment: a potential role for phosphatase and tensin homolog deleted on chromosome ten? (2005) (159)
Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. (1998) (158)
Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. (2000) (158)
Ischaemic preconditioning in a model of global ischaemia: infarct size limitation, but no reduction of stunning. (1995) (156)
Adenosine A(1) receptor induced delayed preconditioning in rabbits: induction of p38 mitogen-activated protein kinase activation and Hsp27 phosphorylation via a tyrosine kinase- and protein kinase C-dependent mechanism. (2000) (156)
Differential cytoprotection against heat stress or hypoxia following expression of specific stress protein genes in myogenic cells. (1995) (155)
Exosomes: Nanoparticles Involved in Cardioprotection? (2014) (153)
The Second Window of Preconditioning (SWOP) Where Are We Now? (2010) (153)
The Preconditioning Phenomenon: A Tool for the Scientist or a Clinical Reality? (2000) (152)
Protecting the ischaemic and reperfused myocardium in acute myocardial infarction: distant dream or near reality? (2000) (151)
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels (2008) (151)
Leptin, the obesity‐associated hormone, exhibits direct cardioprotective effects (2006) (150)
The RISK pathway and beyond (2017) (148)
ESC Working Group Cellular Biology of the Heart: Position Paper: improving the preclinical assessment of novel cardioprotective therapies (2014) (146)
The novel adipocytokine visfatin exerts direct cardioprotective effects (2008) (145)
Remote ischaemic preconditioning involves signalling through the SDF-1α/CXCR4 signalling axis (2013) (143)
Myocardial Ischaemia-reperfusion Injury is Attenuated by Intact Glucagon Like Peptide-1 (GLP-1) in the In Vitro Rat Heart and may Involve the p70s6K Pathway (2007) (142)
Glimepiride, a Novel Sulfonylurea, Does Not Abolish Myocardial Protection Afforded by Either Ischemic Preconditioning or Diazoxide (2001) (141)
Cardioprotection during cardiac surgery. (2012) (139)
Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? (1999) (139)
Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease. Time for reconsideration. (1996) (138)
Ischaemic preconditioning limits infarct size in the rat heart. (1992) (137)
PTEN, the Achilles' heel of myocardial ischaemia/reperfusion injury? (2007) (137)
Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction. (2005) (133)
Stress proteins and myocardial protection. (1992) (132)
Myocardial protection after whole body heat stress in the rabbit is dependent on metabolic substrate and is related to the amount of the inducible 70-kD heat stress protein. (1994) (132)
Targeting Myocardial Reperfusion Injury--The Search Continues. (2015) (131)
Glucagon Like Peptide-1 is Protective Against Myocardial Ischemia/Reperfusion Injury when Given Either as a Preconditioning Mimetic or at Reperfusion in an Isolated Rat Heart Model (2005) (130)
HIF-1 reduces ischaemia-reperfusion injury in the heart by targeting the mitochondrial permeability transition pore. (2014) (129)
Confounding factors in vesicle uptake studies using fluorescent lipophilic membrane dyes (2017) (128)
Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction (2016) (127)
Xanthine oxidase is not a source of free radicals in the ischemic rabbit heart. (1987) (126)
Infarct limitation of the second window of protection in a conscious rabbit model. (1996) (126)
Cyclosporin A and cardioprotection: from investigative tool to therapeutic agent (2012) (126)
Postconditioning protects human atrial muscle through the activation of the RISK pathway (2007) (125)
Insulin therapy as an adjunct to reperfusion after acute coronary ischemia: a proposed direct myocardial cell survival effect independent of metabolic modulation. (2003) (125)
Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or Postconditioning in the Mouse (2008) (125)
Cardiac preconditioning for ischaemia: lost in translation (2010) (123)
Infarct size and nitric oxide synthase in murine myocardium. (2000) (122)
Effect of Remote Ischemic Preconditioning on Acute Kidney Injury in Nondiabetic Patients Undergoing Coronary Artery Bypass Graft Surgery: A Secondary Analysis of 2 Small Randomized Trials (2010) (119)
Ischaemic preconditioning: from mechanisms to exploitation. (1992) (119)
Therapeutic Approaches to Myocardial Infarct Size Limitation (1984) (117)
Evidence for a role for both the adenosine A1 and A3 receptors in protection of isolated human atrial muscle against simulated ischaemia. (1997) (117)
Remote ischemic conditioning: from experimental observation to clinical application: report from the 8th Biennial Hatter Cardiovascular Institute Workshop (2014) (117)
Adenosine A(3) receptor activation protects the myocardium from reperfusion/reoxygenation injury. (2002) (115)
Heat shock protein 27 protects the heart against myocardial infarction (2004) (115)
Pharmacological evidence that inducible nitric oxide synthase is a mediator of delayed preconditioning (1999) (115)
Stable high level expression of a transfected human HSP70 gene protects a heart-derived muscle cell line against thermal stress. (1994) (114)
Realizing the clinical potential of ischemic preconditioning and postconditioning (2005) (114)
Enhancing AMPK activation during ischemia protects the diabetic heart against reperfusion injury. (2011) (114)
The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical (2000) (114)
Time to take myocardial reperfusion injury seriously. (2008) (112)
Leptin-induced cardioprotection involves JAK/STAT signaling that may be linked to the mitochondrial permeability transition pore. (2010) (111)
Novel targets and future strategies for acute cardioprotection: Position Paper of the European Society of Cardiology Working Group on Cellular Biology of the Heart. (2017) (111)
Effect of remote ischemic preconditioning on clinical outcomes in patients undergoing coronary artery bypass graft surgery (ERICCA): rationale and study design of a multi-centre randomized double-blinded controlled clinical trial (2012) (109)
Cardioprotective Effects of Transforming Growth Factor-&bgr;1 During Early Reoxygenation or Reperfusion Are Mediated by p42/p44 MAPK (2001) (108)
Residual Myocardial Iron Following Intramyocardial Hemorrhage During the Convalescent Phase of Reperfused ST-Segment–Elevation Myocardial Infarction and Adverse Left Ventricular Remodeling (2016) (108)
Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts. (1985) (107)
Cardiotrophin-1 can protect cardiac myocytes from injury when added both prior to simulated ischaemia and at reoxygenation. (2001) (106)
Postconditioning Protects Against Endothelial Ischemia-Reperfusion Injury in the Human Forearm (2006) (106)
Mitochondrial K(ATP) channel opening protects a human atrial-derived cell line by a mechanism involving free radical generation. (2001) (106)
Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury (2013) (104)
Prolonging the delayed phase of myocardial protection: repetitive adenosine A1 receptor activation maintains rabbit myocardium in a preconditioned state. (1998) (104)
Preconditioning the human heart during aorto-coronary bypass surgery. (1994) (104)
Myocardial postconditioning: reperfusion injury revisited. (2005) (104)
Specific induction of the 70-kD heat stress proteins by the tyrosine kinase inhibitor herbimycin-A protects rat neonatal cardiomyocytes. A new pharmacological route to stress protein expression? (1996) (104)
Second window of protection following myocardial preconditioning: an essential role for PI3 kinase and p70S6 kinase. (2003) (104)
Cardioprotective growth factors. (2009) (104)
Ischemic and Pharmacological Preconditioning in Girardi Cells and C2C12 Myotubes Induce Mitochondrial Uncoupling (2001) (103)
Ischaemic preconditioning of the vasculature: an overlooked phenomenon for protecting the heart? (2000) (102)
Renal ischemia preconditions myocardium: role of adenosine receptors and ATP-sensitive potassium channels. (1998) (101)
Chronic Metformin Associated Cardioprotection Against Infarction: Not Just a Glucose Lowering Phenomenon (2013) (99)
Cardiotrophin-1 (CT-1) can protect the adult heart from injury when added both prior to ischaemia and at reperfusion. (2002) (99)
Myocardial reperfusion injury - Reply (2007) (97)
Investigating the Signal Transduction Pathways Underlying Remote Ischemic Conditioning in the Porcine Heart (2012) (97)
The role of xanthine oxidase during myocardial ischemia in several species including man. (1988) (96)
The "border zone" in evolving myocardial infarction: controversy or confusion? (1981) (95)
Heat stress limits infarct size in the isolated perfused rabbit heart. (1993) (94)
Remote preconditioning and major clinical complications following adult cardiovascular surgery: systematic review and meta-analysis. (2014) (93)
Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning (2010) (93)
Myocardial protection afforded by nicorandil and ischaemic preconditioning in a rabbit infarct model in vivo. (1998) (93)
The effect of preconditioning (ischemic and pharmacological) on myocardial necrosis following coronary artery bypass graft surgery. (2002) (93)
SGLT2 Inhibitor, Canagliflozin, Attenuates Myocardial Infarction in the Diabetic and Nondiabetic Heart (2019) (92)
The contribution of endothelial nitric oxide synthase to early ischaemic preconditioning: the lowering of the preconditioning threshold. An investigation in eNOS knockout mice. (2001) (90)
Remote Ischemic Conditioning Reduces Myocardial Infarct Size in STEMI Patients Treated by Thrombolysis. (2015) (90)
Ischaemic preconditioning protects hypertrophied myocardium. (1994) (90)
Ischemic preconditioning targets the reperfusion phase (2007) (90)
Genistein, a tyrosine kinase inhibitor, blocks the "second window of protection" 48 h after ischemic preconditioning in the rabbit. (1997) (89)
Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning (2000) (89)
Co-dependence of the neural and humoral pathways in the mechanism of remote ischemic conditioning (2016) (87)
Ischemic preconditioning is lost in aging hypertensive rat heart: Independent effects of aging and longstanding hypertension (2007) (87)
Atorvastatin and Myocardial Reperfusion Injury: New Pleiotropic Effect Implicating Multiple Prosurvival Signaling (2005) (87)
Cardioprotection in the aging, diabetic heart: the loss of protective Akt signalling. (2013) (87)
Dipeptidyl peptidase-4 inhibitors and GLP-1 reduce myocardial infarct size in a glucose-dependent manner (2013) (86)
Preconditioning the diabetic human myocardium (2009) (85)
Time course of delayed myocardial protection after transient adenosine A1-receptor activation in the rabbit. (1997) (84)
Remote ischaemic conditioning reduces infarct size in animal in vivo models of ischaemia-reperfusion injury: a systematic review and meta-analysis (2016) (83)
Adenosine A1 Receptor Activation Induces Delayed Preconditioning in Rats Mediated by Manganese Superoxide Dismutase (2000) (82)
Effect of remote ischaemic conditioning on clinical outcomes in patients presenting with an ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. (2015) (82)
Pharmacologic Therapy That Simulates Conditioning for Cardiac Ischemic/Reperfusion Injury (2014) (81)
Effect of erythropoietin as an adjunct to primary percutaneous coronary intervention: a randomised controlled clinical trial (2011) (80)
Stromal derived factor 1α: A chemokine that delivers a two-pronged defence of the myocardium☆ (2014) (80)
Targeting reperfusion injury in acute myocardial infarction: a review of reperfusion injury pharmacotherapy (2012) (80)
The cytokine storm of COVID-19: a spotlight on prevention and protection (2020) (80)
9th Hatter Biannual Meeting: position document on ischaemia/reperfusion injury, conditioning and the ten commandments of cardioprotection (2016) (80)
Preconditioning and postconditioning: new strategies for cardioprotection (2008) (79)
Adipocytokines, cardiovascular pathophysiology and myocardial protection. (2011) (78)
Exercise directly enhances myocardial tolerance to ischaemia–reperfusion injury in the rat through a protein kinase C mediated mechanism (2001) (78)
Differential protection of primary rat cardiocytes by transfection of specific heat stress proteins. (1996) (77)
Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species. (1991) (76)
Cardioprotection mediated by exosomes is impaired in the setting of type II diabetes but can be rescued by the use of non‐diabetic exosomes in vitro (2017) (74)
Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning (2018) (74)
The cardioprotective and mitochondrial depolarising properties of exogenous nitric oxide in mouse heart. (2003) (74)
Is warm-up in angina ischaemic preconditioning? (1994) (74)
Erythropoietin: ready for prime-time cardioprotection. (2008) (73)
Postconditioning for protection of the infarcting heart (2006) (73)
Transitory Activation of AMPK at Reperfusion Protects the Ischaemic-Reperfused Rat Myocardium Against Infarction (2010) (72)
The 10th Biennial Hatter Cardiovascular Institute workshop: cellular protection—evaluating new directions in the setting of myocardial infarction, ischaemic stroke, and cardio-oncology (2018) (72)
Metformin Prevents Myocardial Reperfusion Injury by Activating the Adenosine Receptor (2009) (72)
Exosomes and cardioprotection – A critical analysis (2017) (72)
Ischemia-reperfusion injury and cardioprotection: investigating PTEN, the phosphatase that negatively regulates PI3K, using a congenital model of PTEN haploinsufficiency (2008) (71)
Slow calcium waves and redox changes precede mitochondrial permeability transition pore opening in the intact heart during hypoxia and reoxygenation. (2012) (70)
Exosomes and Cardiovascular Protection (2016) (69)
Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism. (2016) (69)
Sympathetically induced myocardial ischaemia causes the heart to release plasma kinin. (1987) (68)
Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP (2000) (68)
ATP-sensitive K+Channels Mediate the Delayed Cardioprotective Effect of Adenosine A1Receptor Activation (1999) (67)
DJ-1 protects against cell death following acute cardiac ischemia–reperfusion injury (2014) (66)
Quantitative assessment of cardiac myocyte apoptosis in tissue sections using the fluorescence-based tunel technique enhanced with counterstains. (1999) (65)
Determinants of infarct size during permanent occlusion of a coronary artery in the closed chest dog. (1987) (65)
The effect of cyclosporin-A on peri-operative myocardial injury in adult patients undergoing coronary artery bypass graft surgery: a randomised controlled clinical trial (2014) (65)
β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes (2014) (64)
Necroptosis, necrostatins and tissue injury (2011) (64)
Differential stress protein mRNA expression during early ischaemic preconditioning in the rabbit heart and its relationship to adenosine receptor function. (1995) (63)
Pioglitazone Mimics Preconditioning in the Isolated Perfused Rat Heart: A Role for the Prosurvival Kinases PI3K and P42/44MAPK (2005) (63)
The Diabetic Heart: Too Sweet for Its Own Good? (2012) (63)
Adenosine A1 Agonist at Reperfusion Trial (AART): Results of a Three-Center, Blinded, Randomized, Controlled Experimental Infarct Study (2000) (62)
Mitochondrial cyclophilin-D as a potential therapeutic target for post-myocardial infarction heart failure (2011) (61)
Nitric oxide as a mediator of delayed pharmacological (A(1) receptor triggered) preconditioning; is eNOS masquerading as iNOS? (2002) (60)
Limitation of Myocardial Reperfusion Injury by AMP579, an Adenosine A1/A2A Receptor Agonist: Role of A2A Receptor and Erk1/2 (2003) (59)
Conditioning the whole heart--not just the cardiomyocyte. (2012) (58)
Characterization of the lateral interface between normal and ischemic tissue in the canine heart during evolving myocardial infarction. (1981) (57)
Contrast‐induced acute kidney injury following PCI (2013) (57)
Ischemic Preconditioning: The Concept of Endogenous Cardioprotection (2012) (57)
'Conditioning' the heart during surgery. (2009) (56)
Neural mechanisms in remote ischaemic conditioning in the heart and brain: mechanistic and translational aspects (2018) (56)
Temporal Changes in Myocardial Salvage Kinases During Reperfusion Following Ischemia: Studies Involving the Cardioprotective Adipocytokine Apelin (2007) (55)
The potential for endogenous myocardial antioxidants to protect the myocardium against ischaemia-reperfusion injury: refreshing the parts exogenous antioxidants cannot reach? (1995) (55)
Remote Ischemic Conditioning: A Clinical Trial’s Update (2011) (54)
Sustained limitation of myocardial necrosis 24 hours after coronary artery occlusion: verapamil infusion in dogs with small myocardial infarcts. (1983) (54)
The protective effect of heat stress against reperfusion arrhythmias in the rat. (1993) (54)
Angiotensin-converting enzyme inhibition enhances a subthreshold stimulus to elicit delayed preconditioning in pig myocardium. (2001) (54)
p53 down‐regulation: a new molecular mechanism involved in ischaemic preconditioning (2003) (54)
The influence of the time period between preconditioning ischemia and prolonged ischemia on myocardial protection. (1993) (54)
Erythropoietin protects the human myocardium against hypoxia/reoxygenation injury via phosphatidylinositol‐3 kinase and ERK1/2 activation (2008) (53)
Myocardial Protection: The Pathophysiology of Reperfusion and Reperfusion Injury (1992) (53)
Can beta blockers limit myocardial infarct size? (1986) (52)
The divergent roles of protein kinase C epsilon and delta in simulated ischaemia-reperfusion injury in human myocardium. (2009) (52)
Protein kinase C is involved in resistance to myocardial infarction induced by heat stress. (1997) (51)
Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors. (1996) (51)
Effects of flurbiprofen in altering the size of myocardial infarcts in dogs: reduction or delay? (1983) (50)
Diazoxide-induced respiratory inhibition – a putative mitochondrial KATP channel independent mechanism of pharmacological preconditioning (2005) (49)
SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection. (2017) (49)
Mechanisms of disease: Myocardial reperfusion injury (2007) (49)
The C‐terminal activation domain of the STAT‐1 transcription enhances ischemia/reperfusion‐induced apoptosis in cardiac myocytes (2002) (49)
Role of nuclear factor‐κB activation in acute ischaemia‐reperfusion injury in myocardium (2003) (49)
Myocardial Adaptation, Stress Proteins, and the Second Window of Protection (1996) (49)
Heat stress attenuates free radical release in the isolated perfused rat heart. (1993) (48)
CHARACTERISATION AND VALIDATION OF A MURINE MODEL OF GLOBAL ISCHAEMIA-REPERFUSION INJURY (1998) (48)
There is more to life than revascularization: therapeutic targeting of myocardial ischemia/reperfusion injury. (2011) (48)
The role of PI3Kα isoform in cardioprotection (2017) (48)
Myocardial protection after monophosphoryl lipid A: studies of delayed anti‐ischaemic properties in rabbit heart (1996) (47)
Whole body heat stress fails to limit infarct size in the reperfused rabbit heart. (1992) (47)
Characterization of acute ischemia‐related physiological responses associated with remote ischemic preconditioning: a randomized controlled, crossover human study (2014) (46)
Cardioprotection: The Disconnect Between Bench and Bedside. (2016) (46)
From basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting report from the third international symposium on “New frontiers in cardiovascular research” (2016) (46)
Ischaemic preconditioning reduces infarct size following global ischaemia in the murine myocardium (1998) (46)
Metabolic and flow correlates of myocardial ischaemia. (1983) (46)
ATP-sensitive K+ channels mediate the delayed cardioprotective effect of adenosine A1 receptor activation. (1999) (46)
The sulfonylurea glimepiride does not abolish myocardial protection afforded by either ischemic preconditioning or diazoxide (2000) (45)
Small extracellular vesicles secreted from human amniotic fluid mesenchymal stromal cells possess cardioprotective and promigratory potential (2020) (45)
Quantifying the Area at Risk in Reperfused ST-Segment–Elevation Myocardial Infarction Patients Using Hybrid Cardiac Positron Emission Tomography–Magnetic Resonance Imaging (2016) (44)
From Protecting the Heart to Improving Athletic Performance – the Benefits of Local and Remote Ischaemic Preconditioning (2015) (44)
Assessing mitochondrial potential, calcium, and redox state in isolated mammalian cells using confocal microscopy. (2007) (44)
Automated Extracellular Volume Fraction Mapping Provides Insights Into the Pathophysiology of Left Ventricular Remodeling Post–Reperfused ST‐Elevation Myocardial Infarction (2016) (44)
Characterization of the Langendorff Perfused Isolated Mouse Heart Model of Global Ischemia–Reperfusion Injury (2016) (44)
Myocardial adaptation to ischaemia--the preconditioning phenomenon. (1999) (44)
Enhancing cardiovascular disease risk reduction: raising high-density lipoprotein levels (2009) (44)
The cannabinoid CB1 receptor antagonist, rimonabant, protects against acute myocardial infarction (2009) (44)
Intrinsic cardiac ganglia and acetylcholine are important in the mechanism of ischaemic preconditioning (2017) (43)
A Comparison between Ischemic Preconditioning, Intermittent Cross-Clamp Fibrillation and Cold Crystalloid Cardioplegia for Myocardial Protection during Coronary Artery Bypass Graft Surgery (2002) (41)
Myocardial Protection from Either Ischaemic Preconditioning or Nicorandil Is Not Blocked by Gliclazide (2004) (41)
The pathophysiology of ischaemic preconditioning. (1995) (40)
Myocardial regeneration: expanding the repertoire of thymosin β4 in the ischemic heart (2012) (39)
Bradykinin elicits "second window" myocardial protection in rat heart through an NO-dependent mechanism. (2001) (39)
Adenosine A(1) receptor activation induces delayed preconditioning in rats mediated by manganese superoxide dismutase. (2000) (39)
Rapid assessment of myocardial infarct size in rodents using multi-slice inversion recovery late gadolinium enhancement CMR at 9.4T (2011) (38)
The Caspase 1 Inhibitor VX-765 Protects the Isolated Rat Heart via the RISK Pathway (2018) (37)
Coordinate Regulation of Metabolic Enzyme Encoding Genes During Cardiac Development and Following Carvedilol Therapy in Spontaneously Hypertensive Rats (2000) (37)
Inhibition of NAADP signalling on reperfusion protects the heart by preventing lethal calcium oscillations via two-pore channel 1 and opening of the mitochondrial permeability transition pore (2015) (37)
Human in vivo research on the vascular effects of adenosine. (2008) (36)
The pleiotropic effects of metformin: time for prospective studies (2015) (36)
The Akt1 isoform is an essential mediator of ischaemic preconditioning (2012) (35)
Therapeutic strategies utilizing SDF-1α in ischaemic cardiomyopathy (2017) (35)
Nivolumab in Nonsquamous Non-Small-Cell Lung Cancer (2016) (35)
Ischaemic preconditioning of myocardium: a new paradigm for clinical cardioprotection? (1994) (35)
The ability of heat stress and metabolic preconditioning to protect primary rat cardiac myocytes (1996) (35)
A critical review on the translational journey of cardioprotective therapies! (2016) (35)
Attenuation by heat stress of a submaximal calcium paradox in the rabbit heart. (1993) (35)
Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside (2015) (34)
IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria: guidelines of the EU-CARDIOPROTECTION COST Action (2021) (34)
Preconditioning in isolated superfused rabbit papillary muscles. (1994) (34)
Chronic Erythropoietin Treatment Limits Infarct-size in the Myocardium in Vitro (2005) (33)
Ischaemic preconditioning limits infarct size in the rat heart (1992) (33)
Glimepiride Treatment Facilitates Ischemic Preconditioning in the Diabetic Heart (2013) (33)
The evolving story of “conditioning” to protect against acute myocardial ischaemia–reperfusion injury (2007) (33)
Urocortin: a protective peptide that targets both the myocardium and vasculature. (2009) (33)
Effect of remote ischaemic conditioning on contrast-induced nephropathy in patients undergoing elective coronary angiography (ERICCIN): rationale and study design of a randomised single-centre, double-blind placebo-controlled trial (2013) (32)
Angina reassessed: pain or protector? (1996) (32)
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heart. (1986) (32)
Cangrelor-Mediated Cardioprotection Requires Platelets and Sphingosine Phosphorylation (2016) (32)
Attenuation of myocardial ischaemic injury 24 h after diacylglycerol treatment in vivo. (1997) (32)
A Potential Role for PTEN in the Diabetic Heart (2006) (32)
The role of Caspase 1 in ischemia/reperfusion injury of the myocardium. (2019) (32)
GLP-1 therapy: beyond glucose control. (2008) (32)
Attenuated cardioprotective response to bradykinin, but not classical ischaemic preconditioning, in DOCA-salt hypertensive left ventricular hypertrophy. (2007) (32)
Stress proteins--an endogenous route to myocardial protection: fact or fiction? (1993) (31)
Cardioprotective Properties of the Platelet P2Y12 Receptor Inhibitor, Cangrelor: Protective in Diabetics and Reliant Upon the Presence of Blood (2015) (31)
Circadian variation in acute myocardial infarct size assessed by cardiovascular magnetic resonance in reperfused STEMI patients (2017) (31)
Normothermic transfer times up to 3 min will not precondition the isolated rat heart. (1999) (31)
Sodium-hydrogen exchange in myocardial reperfusion injury (2000) (30)
Myocardial Ischemic Tolerance Following Heat Stress Is Abolished by ATP-Sensitive Potassium Channel Blockade (1997) (30)
Ischaemic preconditioning (1994) (30)
Limitation of infarct size for 24 hours by combined treatment with allopurinol plus verapamil during acute myocardial infarction in the dog. (1987) (30)
Diagnostic performance of T 1 and T 2 mapping to detect intramyocardial hemorrhage in reperfused ST‐segment elevation myocardial infarction (STEMI) patients (2017) (30)
Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. (2008) (30)
Controversies in the cardiovascular management of type 2 diabetes (2010) (29)
Trials, tribulations and speculation! Report from the 7th Biennial Hatter Cardiovascular Institute Workshop (2012) (29)
Role of PI3K in myocardial ischaemic preconditioning: mapping pro‐survival cascades at the trigger phase and at reperfusion (2017) (29)
Mouse models of atherosclerosis and their suitability for the study of myocardial infarction (2020) (29)
Current research views on myocardial reperfusion and reperfusion injury. (1990) (29)
Does remote ischaemic conditioning reduce inflammation? A focus on innate immunity and cytokine response (2021) (28)
Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy: Rationale and Design of the ERIC‐ONC Study—A Single‐Center, Blinded, Randomized Controlled Trial (2016) (28)
Temporal and spatial characteristics of evolving cell injury during regional myocardial ischemia in the dog: the "border zone" controversy. (1983) (27)
A future for remote ischaemic conditioning in high-risk patients (2020) (27)
Heat stress fails to protect myocardium of streptozotocin-induced diabetic rats against infarction. (1999) (27)
Preconditioning and arrhythmias. (2002) (27)
Neuroprotection in Rats Following Ischaemia-Reperfusion Injury by GLP-1 Analogues—Liraglutide and Semaglutide (2019) (27)
Apelin exhibits cardioprotection against ischaemia reperfusion injury (2007) (26)
Increased endogenous catalase activity caused by heat stress does not protect the isolated rat heart against exogenous hydrogen peroxide. (1994) (26)
Mibefradil, a T-Type and L-Type Calcium Channel Blocker, Limits Infarct Size through a Glibenclamide-Sensitive Mechanism (1999) (26)
Inability of desferrioxamine to limit tissue injury in the ischaemic and reperfused rabbit heart. (1989) (25)
Analysis of the association of a heat shock protein70-1 gene promoter polymorphism with myocardial infarction and coronary risk traits. (1998) (25)
Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection (2013) (24)
Role of nuclear factor-kappa B activation in acute ischaemia-reperfusion injury in myocardium. (2003) (24)
Immediate remote ischemic postconditioning after hypoxia ischemia in piglets protects cerebral white matter but not grey matter (2015) (23)
The Cardioprotective Actions of Leptin Are Lost in the Zucker Obese (fa/fa) Rat (2009) (23)
Delayed or Second Window Preconditioning Induced by Adenosine A1 Receptor Activation Is Independent of Early Generation of Nitric Oxide or Late Induction of Inducible Nitric Oxide Synthase (2001) (23)
SB 203580, a Mitogen-Activated Protein Kinase Inhibitor, Abolishes Resistance to Myocardial Infarction Induced by Heat Stress (2000) (23)
Increased production of functional small extracellular vesicles in senescent endothelial cells (2020) (23)
Hydralazine protects the heart against acute ischaemia/reperfusion injury by inhibiting Drp1-mediated mitochondrial fission (2021) (22)
Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke (2021) (22)
Evolving myocardial infarction in the rat in vivo: an inappropriate model for the investigation of drug-induced infarct size limitation during sustained regional ischaemia. (1988) (22)
Failure to recapture cardioprotection with high-dose atorvastatin in coronary artery bypass surgery: a randomised controlled trial (2011) (22)
Ischaemic preconditioning reduces troponin-T release in patients undergoing cardiac surgery (1996) (22)
Protection afforded by allopurinol in the first 24 hours of coronary occlusion is diminished after 48 hours. (1988) (22)
Ischaemic preconditioning may abolish the protection afforded by ATP-sensitive potassium channel openers in isolated human atrial muscle (1997) (21)
Global myocardial ischemia protects the myocardium from subsequent regional ischemia. (1993) (21)
Mitochondrial K channel opening protects a human atrial-derived (2001) (21)
Infarct size‐reducing effect of heat stress and α1 adrenoceptors in rats (1998) (21)
Correction: Loss of PINK1 Increases the Heart's Vulnerability to Ischemia-Reperfusion Injury (2013) (20)
Targeting myocardial ischaemic injury in the absence of reperfusion (2020) (20)
Hsp70 in myocardial ischaemia (1994) (20)
Prodromal angina limits infarct size: a role for ischemic preconditioning. (1995) (19)
A retrospective analysis of myocardial preservation techniques during coronary artery bypass graft surgery: are we protecting the heart? (2014) (19)
Phentolamine and preconditioning during coronary angioplasty. (1998) (19)
Exogenous Administration of Recombinant MIF at Physiological Concentrations Failed to Attenuate Infarct Size in a Langendorff Perfused Isolated Mouse Heart Model (2016) (19)
Spotlight on preconditioning. (2002) (19)
Unique morphological characteristics of mitochondrial subtypes in the heart: the effect of ischemia and ischemic preconditioning. (2017) (19)
Ischaemic Preconditioning Protects Cardiomyocytes from Anthracycline-Induced Toxicity via the PI3K Pathway (2018) (19)
Myocardial preconditioning. What have we learned? (1997) (19)
A single five minute period of rapid atrial pacing fails to limit infarct size in the in situ rabbit heart. (1993) (19)
Heat stress response and myocardial protection (1999) (18)
Characterization of muscle oxygenation response to vascular occlusion: implications for remote ischaemic preconditioning and physical Performance (2017) (18)
“Conditional Conditioning” in cardiac bypass surgery (2012) (18)
Exogenous SDF-1α Protects Human Myocardium from Hypoxia-Reoxygenation Injury via CXCR4 (2015) (17)
Neutrophil gelatinase-associated lipocalin prior to cardiac surgery predicts acute kidney injury and mortality (2017) (17)
Influence of Allopurinol Plus Verapamil Treatment on Myocardial Tissue Necrosis During Permanent Coronary Occlusion in Canine Hearts with Small Infarcts (1989) (17)
Metformin use and cardiovascular outcomes after acute myocardial infarction in patients with type 2 diabetes: a cohort study (2019) (17)
The molecular basis of adaptation to ischemia in the heart: the role of stress proteins and anti-oxidants in the ischemic and reperfused heart. (1996) (17)
The GTN patch: a simple and effective new approach to cardioprotection? (2018) (17)
Quantifying the Area-at-Risk in Reperfused STEMI Patients Using Hybrid Cardiac PET-MR Imaging (2016) (16)
The Role of Extracellular DNA and Histones in Ischaemia-Reperfusion Injury of the Myocardium (2020) (16)
REPERFUSION INJURY - DEFINITIONS AND HISTORICAL BACKGROUND (1992) (16)
ATP dependent K+ channel: a novel therapeutic target in unstable angina. (1999) (16)
Current trends and controversies in ischemia-reperfusion research (2003) (15)
The importance of clinically relevant background therapy in cardioprotective studies (2020) (15)
Combination Therapy to Target Reperfusion Injury After ST-Segment–Elevation Myocardial Infarction: A More Effective Approach to Cardioprotection (2017) (15)
Ischemic preconditioning reduces troponin T release in patients undergoing coronary artery bypass grafts. (1996) (15)
Inability of metoprolol to achieve a sustained limitation of infarct size 24 h after coronary artery embolization in the closed chest dog. (1984) (15)
Hypoxic preconditioning of ischaemic myocardium. (1992) (15)
Ischaemic preconditioning is not prevented by inhibition of endothelium-derived nitric oxide (1992) (15)
Clinical translation of cardioprotective strategies (2008) (15)
DO FREE-RADICALS CONTRIBUTE TO MYOCARDIAL-CELL DEATH DURING ISCHEMIA - REPERFUSION (1992) (15)
A high velocity impact device for obtaining multiple, contiguous, myocardial biopsies. (1981) (15)
Comparison of the Protective Effects of a Highly Selective ATP-Sensitive Potassium Channel Opener and Ischemic Preconditioning in Isolated Human Atrial Muscle (1997) (14)
Attenuation of reperfusion-induced ventricular fibrillation in the rat isolated hypertrophied heart by preischemic diltiazem treatment (1993) (14)
Pharmacological preconditioning of primary rat cardiac myocytes by FK506 (1996) (14)
Delayed Preconditioning and Adaptive Cardioprotection (2012) (14)
The coronary collateral circulation during regional myccardial ischemia: A comparative study in eight species (1984) (14)
Failure of the Adipocytokine, Resistin, to Protect the Heart From Ischemia-Reperfusion Injury (2011) (14)
Spinal cord stimulation or ischaemic preconditioning? (1993) (14)
Taking lizard saliva to heart. (2012) (14)
Pre-conditioning with adenosine leads to concentration-dependent infarct size reduction in the isolated rabbit heart. (1996) (14)
Extracellular histones are a target in myocardial ischaemia–reperfusion injury (2021) (14)
Reduction of Infarct Size in Isolated Rat Heart by CsA and FK506: Possible Role of Phosphatase Inhibition (1998) (13)
Preconditioning the human myocardium: Recent advances and aspirations for the development of a new means of cardioprotection in clinical practice (1995) (13)
Up-regulation and alternative splicing of the IGF-1 gene in the rabbit heart following a brief pressure/volume overload (1998) (13)
Amp579, an A1/A2a agonist, limits infarct size at reperfusion via a p42/p44 MAPK-dependent pathway (2000) (13)
Is there a component of coronary collateral flow which cannot be detected by radiolabelled microspheres? (1987) (13)
Backtable heat-enhanced preconditioning: a simple and effective means of improving function of heart transplants. (2001) (13)
The Effect of Remote Ischemic Conditioning and Glyceryl Trinitrate on Perioperative Myocardial Injury in Cardiac Bypass Surgery Patients: Rationale and Design of the ERIC‐GTN Study (2015) (13)
Heat stress-induced resistance to myocardial infarction in the isolated heart from transgenic [(mREN-2)27] hypertensive rats. (1998) (13)
Omapatrilat Limits Infarct Size and Lowers the Threshold for Induction of Myocardial Preconditioning Through a Bradykinin Receptor-Mediated Mechanism (2004) (13)
Neuroprotection by remote ischemic conditioning in the setting of acute ischemic stroke: a preclinical two-centre study (2020) (13)
Myocardial Infarct Size Reduction Provided by Local and Remote Ischaemic Preconditioning: References Values from the Hatter Cardiovascular Institute (2018) (13)
Effect of Remote Ischaemic preconditioning on Clinical outcomes in patients undergoing Coronary Artery bypass graft surgery (ERICCA study): a multicentre double-blind randomised controlled clinical trial (2016) (12)
Spatial and temporal characteristics of the transmural distribution of collateral flow and energy metabolism during regional myocardial ischemia in the dog. (1987) (12)
Effect of remote ischaemic conditioning on platelet reactivity and endogenous fibrinolysis in ST-elevation myocardial infarction- a substudy of the CONDI-2/ERIC-PPCI randomised controlled trial. (2020) (12)
A HEAT-SHOCK PROTEIN-70 TRANSGENE RESULTS IN MYOCARDIAL PROTECTION (1994) (12)
Loss of PINK 1 Increases the Heart ’ s Vulnerability to Ischemia-Reperfusion Injury (2013) (12)
Delayed myocardial protection following ischaemic preconditioning (2004) (12)
Mitochondrial PINK1—A Novel Cardioprotective Kinase? (2008) (12)
Mitochondrial DNA damage, oxidative stress, and atherosclerosis: where there is smoke there is not always fire. (2013) (12)
Translation of experimental cardioprotective capability of P2Y12 inhibitors into clinical outcome in patients with ST-elevation myocardial infarction (2021) (12)
Letter to the editor: "Zinc and cardioprotection: the missing link". (2009) (12)
Stromal cell-derived factor-1α signals via the endothelium to protect the heart against ischaemia-reperfusion injury (2019) (11)
Melatonin as a cardioprotective therapy following ST-segment elevation myocardial infarction: is it really promising? Reply. (2017) (11)
The Derivation of Primary Human Epicardium-Derived Cells. (2015) (11)
WHOLE-BODY HEAT-STRESS PROTECTS THE ISOLATED PERFUSED RABBIT HEART (1990) (11)
A 2ND WINDOW OF PROTECTION 24 HOURS AFTER ISCHEMIC PRECONDITIONING MAY BE DEPENDENT UPON ADENOSINE RECEPTOR ACTIVATION (1993) (11)
Myocardial protection: is primary PCI enough? (2009) (11)
Regression of left ventricular hypertrophy and susceptibility to reperfusion-induced arrhythmias after DOCA-salt hypertension in the rat. (1992) (11)
Infarct size-reducing effect of heat stress and alpha1 adrenoceptors in rats. (1998) (10)
Novel treatment strategies (2012) (10)
Cardioprotection by pre-infarct angina: is it ischaemic preconditioning? (1998) (10)
A multiple biopsy gun for the study of three-dimensional metabolic geometry [proceedings]. (1979) (10)
Protection Against Global Ischemia in the Rabbit Isolated Heart 24 Hours After Transient Adenosine A1 Receptor Activation (1994) (10)
The protection observed during delayed preconditioning of the heart appears independently of iNOS: A study in iNOS knockout mice (1999) (10)
Postconditioning - A form of "modified reperfusion" protects the myocardium by activating the P13K-Akt pathway (2004) (10)
Current trends and controversies in ischemia-reperfusion research--meeting report of the Hatter Institute 3rd International Workshop on Cardioprotection. (2003) (10)
PRECONDITIONING PROTECTS ISOLATED HUMAN MUSCLE (1993) (9)
Endothelial Insulin Resistance Protects the Heart Against Prolonged Ischemia–Reperfusion Injury But Does Not Prevent Insulin Transport Across the Endothelium in a Mouse Langendorff Model (2014) (9)
Diabetes, incretin hormones and cardioprotection (2014) (9)
Remote ischaemic conditioning: defining critical criteria for success—report from the 11th Hatter Cardiovascular Workshop (2022) (9)
Assessing the effects of mitofusin 2 deficiency in the adult heart using 3D electron tomography (2017) (9)
STAT5 fits the RISK profile for cardioprotection (2012) (9)
27 Exosomes Released from Endothelial Cells are Cardioprotective (2014) (8)
Cell membrane repair as a mechanism for ischemic preconditioning? (2010) (8)
Infarct-size limitation--real or artifactual. Studies with flurbiprofen using a reperfusion model. (1985) (8)
SGLT 2 inhibitor, Canagliflozin attenuates myocardial infarction in the diabetic and non-diabetic heart (2018) (8)
Protection by ischaemic preconditioning appears independent of stress protein synthesis (1991) (8)
The Mitochondrial Permeability Transition Pore as a Target for Cardioprotection in Hypertrophic Cardiomyopathy (2013) (8)
Both protein kinase C and protein tyrosine kinase mediate adenosine induced delayed cardioprotection in rabbits (1997) (8)
Abrupt withdrawal of chronic beta-blockade: adaptive changes in cyclic AMP and contractility. (1981) (8)
Myocardial Stress Response, Cytoprotective Proteins and the Second Window of Protection Against Infarction (1996) (7)
Activation of the pro-survival kinases (PI3 kinase-Akt and Erk 1/2) at reperfusion is essential for preconditioning-induced protection (2003) (7)
Effect of remote ischaemic conditioning on infarct size and remodelling in ST-segment elevation myocardial infarction patients: the CONDI-2/ERIC-PPCI CMR substudy (2021) (7)
Heat Stress Proteins and Their Relationship to Myocardial Protection (1999) (7)
Ischaemic preconditioning: a clinical perspective. (1998) (7)
162 Polymersomes Functionalized with HSP70 – Novel, Synthetic Cardioprotective Nanovesicles (2016) (7)
Preconditioning and postconditioning : (2009) (7)
Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance (2017) (7)
The effects of ischemia on metabolism and reperfusion arrhythmias. (1983) (7)
Myocardial salvage with allopurinol during 24 h of permanent coronary occlusion: importance of pretreatment. (1988) (7)
Corrigendum to “‘Conditioning’ the heart during surgery” [Eur. J. Cardiothorac. Surg. 35 (6) (2009) 977–987] (2009) (6)
TEMPORAL CHARACTERIZATION OF THE 2ND WINDOW OF PROTECTION - PROLONGED ANTI-INFARCT EFFECT AFTER ADENOSINE-A1-RECEPTOR ACTIVATION (1994) (6)
Inability of dimethylthiourea to limit tissue necrosis during acute myocardial infarction in rabbits. (1992) (6)
Is Mediated via Akt and p 70 s 6 Kinase Cell-Survival Signaling Myocardial Protection by Insulin at Reperfusion Requires Early Administration (2001) (6)
Postconditioning does not protect the diabetic heart (2006) (6)
Remote ischaemic conditioning: building evidence of efficacy. (2014) (6)
The role of nitric oxide in mitochondria. Focus on "Modulation of mitochondrial Ca2+ by nitric oxide in cultured bovine vascular endothelial cells". (2005) (6)
24 Protecting the Heart at a Distance: Exosomes for nano-sized Cardioprotection (2014) (6)
Enhanced Protection of Heat Shock in Myocardial Infarction: Inhibition of Detrimental Effect of Systemic Hyperthermia (1999) (6)
Remote ischaemic preconditioning for coronary artery bypass grafting (2015) (6)
Calcium antagonists and evolving myocardial infarction: studies of the effects of nifedipine on tissue ATP, collateral flow and infarct size in the closed chest dog. (1986) (6)
Adenosine-Induced Second Window of Protection is Mediated by Inhibition of Mitochondrial Permeability Transition Pore Opening at the Time of Reperfusion (2004) (6)
Exercise induced ischemia results in both early and delayed myocardial adaptation: No role for adenosine? (2000) (6)
Verapamil and nifedipine limit infarct size in the dog. (1983) (6)
Diltiazem reduced infarct size but not ventricular arrhythmias in 48 hour coronary embolized dogs. (1985) (5)
Dissociating HDL cholesterol from cardiovascular risk (2010) (5)
Lancet Seminar: Cardiovascular Remodelling in Coronary Artery Disease and Heart Failure + (2015) (5)
Glucagon like peptide-1 (GLP-1) provides protection against cardiac ischaemia/reperfusion injury in both in vivo and in vitro experimental model in the rat (2004) (5)
Management of myocardial reperfusion injury (2012) (5)
Surgery: Remote ischaemic conditioning—approaching prime time? (2013) (5)
Nifedipine limits infarct size for 24 hours in closed chest coronary embolized dogs (2005) (5)
Long acting calcium antagonist anipamil limits myocardial necrosis and penetrates the ischemic zone during 24 h of coronary artery occlusion in the dog. (1990) (5)
A new era in the management of type 2 diabetes: Is cardioprotection at long last a reality? (2017) (5)
AJP MS H-00902-2002-R1 FINAL ACCEPTED VERSION B-TYPE NATRIURETIC PEPTIDE (BNP) LIMITS INFARCT SIZE IN RAT ISOLATED HEART VIA KATP CHANNEL OPENING (2003) (5)
ATP-dependent potassium channel openers and preconditioning. (1993) (5)
Ischaemic preconditioning causes rapid elevation of 65kDa stress protein in rabbit heart (1992) (5)
Xanthine oxidase-derived free radicals as contributors to early ischemic injury in dog hearts (1984) (5)
A highly selective ATP-dependent potassium channel opener mimics ischaemic preconditioning protection in isolated human atrium (1996) (5)
The influence of the time period between ischemic preconditioning and prolonged ischemia on myocardial protection (1992) (5)
The mitochondrial permeability transition pore in myocardial preconditioning. (2004) (5)
The glucose hypothesis: Updated or outdated? Role of insulin. (2004) (5)
Vitamin E and coronary heart disease (1996) (5)
The current status of stunning, hibernation, and preconditioning (1993) (5)
A novel recombinant antibody specific to full-length stromal derived factor-1 for potential application in biomarker studies (2017) (5)
Exosomes from neuronal stem cells may protect the heart from ischaemia/reperfusion injury via JAK1/2 and gp130 (2021) (5)
FC1 Dipeptidyl peptidase IV inhibitors limit myocardial infarct size in a glucose-sensitive manner (2010) (5)
Changes in myosin light chain phosphorylation during regional myocardial ischaemia (1981) (4)
FLURBIPROFEN MAY LIMIT INFARCT SIZE 6 BUT NOT 24 HOURS FOLLOWING CORONARY-OCCLUSION IN THE DOG (1982) (4)
Myocardial Protection and the KATP Channel (1995) (4)
TEMPORAL CHARACTERIZATION OF THE 2ND WINDOW OF PROTECTION - DURATION OF THE ANTI-INFARCT EFFECT AFTER ISCHEMIC PRECONDITIONING (1995) (4)
Premature meta-analysis of remote ischemic preconditioning. (2009) (4)
Effect of Okadaic Acid, a Protein Phosphatase Inhibitor, on Heat Stress-Induced HSP72 Synthesis and Thermotolerance (2000) (4)
HSP and cytoskeletal protein expression and localisation during delayed preconditioning in the rabbit heart (1998) (4)
Prolonging the delayed phase of cardioprotection by repetitive adenosine A1 receptor activation (1997) (4)
Wake Up and Smell the Coffee: Yet Another No Go for Cardiac Patients? (2008) (4)
Cardiotrophin-1 reduces infarct size in isolated heart model via a MAP kinase dependent pathway (1999) (4)
Angina: Who Needs It? Cardioprotection in the Preconditioning Era (1998) (4)
Genistein, a tyrosine kinase inhibitor, blocks the second window of protection 48 hours after ischaemic preconditioning (1997) (4)
Promising strategies to minimize reperfusion injury in STEMI. (2016) (4)
Oxidative stress and the second window of protection after preconditioning [8] (1996) (4)
Can acute preconditioning be mimicked and exploited with pharmacological agents (1997) (4)
Invited editorial: Time to take reperfusion injury seriously? (2008) (4)
Ischaemic Preconditioning and Postconditioning do not Affect Adenosine A1 and A2A Receptor Sensitivity (2009) (4)
Delayed Preconditioning Against Lethal Ischaemic Injury (1998) (4)
Ischemic Preconditioning: from Bench to Bedside (2002) (4)
Can glucagon-like peptide-1 (GLP-1) analogues make neuroprotection a reality? (2020) (4)
Does hyperglycemia reduce proliferation or increase apoptosis? (2006) (4)
Is this truly ischemic preconditioning? (2006) (4)
Oxygen-Derived Free Radicals and Myocardial Injury: A Critical Role for Xanthine Oxidase?1 (1986) (4)
Do We Really Need Aspirin Loading for STEMI? (2022) (4)
Unstable angina REPORT OF A MEETING OF PHYSICIANS AND SCIENTISTS, UNIVERSITY COLLEGE LONDON MEDICAL SCHOOL (1993) (4)
THE EFFECT OF ALLOPURINOL ON MYOCARDIAL INFARCT SIZE IN RAT VS RABBIT - THE CONTRIBUTION OF XANTHINE-OXIDASE (1985) (4)
Myocardial infarct size attenuation by glucagon like peptide-1 (GLP-1) in both in vivo and in vitro rat heart (2004) (4)
Involvement of protein kinases and manganese-superoxide dismutase in adenosine induced delayed preconditioning (1998) (4)
Poster session 2 (2004) (4)
DIFFERENCES IN THE ABILITY OF TRANSFECTED HSP70 AND HSP90 GENES TO PROTECT H9C2 MYOCYTES AGAINST HET STRESS AND HYPOXIA (1994) (4)
Hatter Institute Workshop on Myocardial Preconditioning, Cape Town, April 1998 (1998) (3)
Evaluating early and delayed cardioprotection by plasma exosomes in simulated ischaemia–reperfusion injury (2015) (3)
Heat stress attenuates a submaximal calcium paradox in the rabbit (1992) (3)
Microvascular incompetence and the failure of hearts to recover contractile function after cardioplegia. (1995) (3)
Protecting the myocardium at time of reperfusion--Meeting report of the Hatter Institute 4th International Workshop on Cardio-protection. (2005) (3)
Anipamil limits myocardial necrosis in the closed chest dog doring 24 hours of coronary artery occlusion (1986) (3)
Representational difference analysis of cDNA identifies novel genes expressed following preconditioning of the heart (2005) (3)
Protecting the myocardium at time of reperfusion (2005) (3)
HEAT-STRESS LIMITS INFARCT SIZE IN THE ISOLATED RABBIT HEART (1992) (3)
Changes in myocardial collagen content after chronic doca-salt hypertension in the rat (1992) (3)
Adenosine-induced increase in myocardinal ATP: Are there beneficial effects for the ischaemic myocardium? (1989) (3)
The "Border zone" and myocardial protection: a time for reassessment? (2009) (3)
p38 MAPK appears to be involved in the cytoprotective effect of insulin therapy administrated at reperfusion (2006) (3)
Cyclic AMP and early contractile failure. (1983) (3)
Myocardial salvage by pharmacological interventions (1984) (3)
Limitation of myocardial necrosis with verapamil during sustained coronary occlusion in the closed-chest dog (1988) (3)
Characterisation and validation of a new murine model of global ischaemia-reperfusion injury (2004) (3)
Insulin modifies myocyte apoptosis and reduces myocardial infarct size when administered at reperfusion: A novel mechanism of protection (1999) (3)
Cardioprotection - is no the answer? A renewed look at nitric oxide signalling in cardiomyocytes. (2018) (3)
INHIBITION OF ENDOTHELIUM-DERIVED NITRIC-OXIDE REDUCES INFARCT SIZE (1992) (3)
Stress proteins: a future role in cardioprotection? (1996) (3)
Caspase inhibition at reperfusion protects the isolated rat heart (1999) (3)
SPECIFIC INDUCTION OF HSP72 BY HERBIMYCIN-A PROTECTS CARDIOMYOCYTES - A PHARMACOLOGICAL ROUTE TO CYTOPROTECTION (1995) (3)
Oxidative stress and the second window of protection after preconditioning. (1996) (3)
Dissecting out the mechanism of cardioprotection by endogenous erthyropoietin using genetic engineering. (2006) (2)
M itochondrial K channels: role in cardioprotection (2002) (2)
Negative interaction between nitrates and remote ischemic preconditioning in patients undergoing cardiac surgery: the ERIC-GTN and ERICCA studies (2022) (2)
ACE-inhibition enhances a subthreshold stimulus for delayed preconditioning (1999) (2)
Remote Ischemic Preconditioning and Cardiac Surgery. (2016) (2)
Apelin, the potentially therapeutic adipocytokine, protects against myocardial ischemia-reperfusion injury (2007) (2)
Pathophysiology of irreversible ischemic injury. The border zone controversy. (1983) (2)
Remote Ischaemic Conditioning in STEMI Patients in Sub-Saharan AFRICA: Rationale and Study Design for the RIC-AFRICA Trial (2021) (2)
Delta opioid receptors mediate ischaemic preconditioning in the isolated rat heart (1998) (2)
Stress proteins, heat stress and myocardial protection (1994) (2)
Urocortin: a few inflammatory remarks. (2009) (2)
Paradigm shifts in cardioprotection research: the importance of the MPTP as a therapeutic target (2012) (2)
The effect of Heat Stress on infarct size in blood vs buffer perfused rabbit hearts (1992) (2)
Late gadolinium enhanced MRI in small animal models of myocardial infarction (2010) (2)
Myocardial reperfusion and reperfusion injury: current views. (1991) (2)
by Activating the Phosphatidylinositol 3-Kinase-Akt Pathway Postconditioning: A Form of "Modified Reperfusion" Protects the Myocardium (2008) (2)
Transforming growth factor beta 1 attenuates myocardial injury when given at reperfusion (1999) (2)
Ventilation strategy has a major influence on remote ischaemic preconditioning in mice (2017) (2)
Remote ischaemic preconditioning reduces renal injury in patients undergoing coronary artery bypass graft surgery (2009) (2)
Does nifedipine cause a sustained limitation of infarct size during permanent coronary artery occlusion in the dog (1986) (2)
Remote ischaemic preconditioning protects the heart at time of CABG surgery (2007) (2)
REDUCTION OF INFARCT SIZE FOLLOWING NITRIC-OXIDE INHIBITION IS DUE TO COMPENSATORY ADENOSINE RELEASE (1993) (2)
3D ELECTRON MICROSCOPY TOMOGRAPHY TO ASSESS MITOCHONDRIAL MORPHOLOGY IN THE ADULT HEART (2014) (2)
4 Characterisation of Mitochondrial Morphology in the Adult Rodent Heart (2014) (2)
Xenon: A Noble Member of the Cardioprotection Club. (2017) (2)
123 THE EFFECTS OF MULTI-LIMB REMOTE ISCHAEMIC PRECONDITIONING IN PATIENTS UNDERGOING CARDIAC BYPASS SURGERY (2013) (2)
Poster Session 2 (2009) (2)
Novel cardioprotective agents in acute coronary syndromes: a role for nicorandil? (1998) (2)
Cardioprotective role of insulin at reperfusion may in part be due to an anti-apoptotic mechanism (1999) (2)
Infarct size limitation: Temporal characteristics of transmural gradients of flow andmetabolism in the canine myocardium during evolving myocardial infarction (1984) (2)
DELAYED CARDIOPROTECTION AFTER MONOPHOSPHORYL LIPID-A TREATMENT IS NOT ASSOCIATED WITH ELEVATION OF MYOCARDIAL 70 KDA STRESS PROTEIN (1995) (2)
Correction: Hearts deficient in both Mfn1 and Mfn2 are protected against acute myocardial infarction (2021) (2)
Adenosine A 1 Receptor Induced Delayed Cardioprotection: Investigation into Time-Course and Cellular Mechanisms (1999) (2)
The re-introduction of ischemic preconditioning is able to protect myocardium after repeated long reperfusion intervals. (1994) (2)
The cardioprotective effect of atorvastatin—Is there a role for the adenosine receptor? (2008) (2)
37 A novel role for DJ-1 in cardioprotection (2011) (2)
Protection From Cardiac Ischemia-Reperfusion Injury by Epigenetic Regulation of NADPH Oxidase (2018) (2)
LIMITATION OF MYOCARDIAL INFARCT SIZE IN CORONARY EMBOLIZED DOGS BY NIFEDIPINE (1983) (1)
Ischaemic preconditioning : present position and future directions 1 (1997) (1)
Novel therapeutic concepts Myocardial reperfusion injury : looking beyond primary PCI (2013) (1)
Comprar Management of Myocardial Reperfusion Injury | Juan Carlos Kaski | 9781849960182 | Springer (2012) (1)
Using multiphoton microscopy to examine the response of the heart to ischaemia and reperfusion injury (2008) (1)
26 Chronic Saxagliptin Treatment in a Diabetic Rat Model Protects against Infarction Independently of its Glucose Lowering Capacity (2014) (1)
Effect of Remote Ischaemic Conditioning on the Inflammatory Cytokine Cascade of COVID-19 (RIC in COVID-19): a Randomized Controlled Trial (2022) (1)
INFARCT SIZE-REDUCTION BY PRECONDITIONING IS NOT DUE TO THE OPENING OF ATP-SENSITIVE POTASSIUM CHANNELS IN REGIONALLY ISCHEMIC RABBIT HEARTS (1995) (1)
The mitochondrial permeability transition pore is a functional target for cardioprotection in human hypertrophic cardiomyopathy (2010) (1)
Pharmacological preconditioning of the heart during surgery Reply (2010) (1)
Myocardial Reperfusion Injury as a New Frontier for Clinical Therapy (2012) (1)
Adenosine A(1) receptor induced late preconditioning: Role of nitric oxide synthase (NOS) (1999) (1)
Letter by Takov et al Regarding Article, "Fabrication of Synthetic Mesenchymal Stem Cells for the Treatment of Acute Myocardial Infarction in Mice". (2017) (1)
Atorvastatin at reperfusion attenuates myocardial infarction by the induction of heat shock protein 27 and p38 MAPK in the isolated perfused mouse heart (2004) (1)
Targeting Mitochondrial Fusion and Fission to Prevent Atherosclerosis: Getting the Balance Right (2019) (1)
MYOCARDIAL RESISTANCE TO HYPOXIA IS RELATED TO THE CONTENT OF THE 72KDA STRESS PROTEIN (1992) (1)
Myocardial infarct size limitation. Principles, problems and possibilities. (1984) (1)
Abstract 10281: Cangrelor’s Anti-Infarct Effect Requires Phosphorylation of Sphingosine in Platelets: The Missing Link (2015) (1)
REMOTE ISCHAEMIC PRECONDITIONING AND POSTCONDITIONING AND THE REPERFUSION INJURY SALVAGE KINASE PATHWAY (2009) (1)
HSP expression and protection after heat stress in myogenic cells, and after simulated ischemia in cardiomyocytes, are protein kinase C-dependent. (1996) (1)
The effect of combination therapy on infarct size limitation in the dog (1985) (1)
Role of inducible nitric oxide synthase in delayed ischaemic preconditioning (1998) (1)
The effect of aging on the ability to protect the rat heart from ischaemia/reperfusion injury. (2000) (1)
Flurbiprofen causes an apparent but not real limitation of infarct size in the dog (1983) (1)
The role of nitric oxide in mitochondria . Focus on “ Modulation of mitochondrial Ca 2 by nitric oxide in cultured bovine vascular endothelial cells ” (2005) (1)
Involvement of delta opioid receptor subtypes in ischaemic preconditioning against infarction in the rat isolated heart (1998) (1)
Slow calcium waves and redox changes precede mPTP opening occur during hypoxia and reoxygenation in the intact heart (2012) (1)
Cardioprotective actions of the novel adipocytokine visfatin (2007) (1)
LIMB REMOTE ISCHAEMIC POST-CONDITIONING PROTECTS CEREBRAL WHITE MATTER IN A PIGLET MODEL OF PERINATAL ASPHYXIA (2016) (1)
Inhibiting mitochondrial permeability transition pore opening protects the human myocardium from ischemia-reperfusion injury (2004) (1)
Myocardial ischaemic tolerance following heat stress is abolished by blockade of the ATP-sensitive potassium channel (1997) (1)
014 Atorvastatin protects human myocardium from lethal ischaemia-reperfusion injury by activating the risk pathway (2010) (1)
Metformin cardioprotects the diabetic heart by inhibiting mPTP opening via the risk pathway (2007) (1)
Diabetes raises the threshold for protection in the human muscle subjected to simulated ischaemia-reperfusion injury (2008) (1)
Myocardial Ischemia: Mechanisms, Reperfusion, Protection (1996) (1)
Insulin inhibits opening of the mitochondrial permeability transition pore via the reperfusion injury salvage kinase (RISK) pathway (2004) (1)
238 RAT PLASMA EXOSOMES ARE CARDIOPROTECTIVE (2013) (1)
Can high-dose atorvastatin provide cardioprotection during coronary artery bypass surgery? (2008) (1)
Ischemic preconditioning and mitochondrial K-ATP channel activation protect the myocardium by inhibiting mitochondrial permeability transition pore opening (2002) (1)
Metformin reduces myocardial infarct size through the Akt-mediated inhibition of mitochondrial permeability transition pore opening in both diabetic Goto Kakizaki and Wistar rat heart in vitro (2007) (1)
Remote Ischemic Preconditioning Protects Against Endothelial Dysfunction in a Human Model of Systemic Inflammation: A Randomized Clinical Trial (2021) (1)
Implications of p38 map kinase and K ATP channels in the heart stress-induced myocardial protection. (1998) (1)
Do Heat Shock Proteins Play a Role in Myocardial Preconditioning (1997) (1)
Invited commentaries on Professor Parratt's letter (1993) (1)
Transforming growth factor beta 1 limits infarct size when administered prior to reperfusion in an isolated rat heart model (1999) (1)
PROTECTING THE ISCHAEMIC MYOCARDIUM USING HEAT STRESS AND ISCHAEMIC PRECONDITIONING (1997) (1)
THE FAILURE OF WHOLE-BODY HEAT-SHOCK TO LIMIT INFARCT SIZE IN THE ISCHEMIC AND REPERFUSED RABBIT HEART (1991) (1)
BS16 The role of parasympathetic nervous system in the infarct-limiting effect of SGLT2 inhibitors (2021) (1)
PRECONDITIONING THE HUMAN HEART DURING CORONARY-ARTERY BYPASS-SURGERY (1993) (1)
Dexmedetomidine protects the heart against ischemia-reperfusion injury by an eNOS / NO / PKG dependent mechanism (2016) (1)
Comparison of ischaemic preconditioning and a highly selective ATP-dependent potassium (1996) (1)
EFFECT OF PROTEIN-KINASE-C INHIBITION DURING ISCHEMIC PRECONDITIONING OF THE 2ND WINDOW OF PROTECTION IN THE RABBIT (1995) (1)
Protein phosphatase inhibitors reduce infarct size in the isolated rat heart (1998) (1)
Type-B natriuretic peptide limits infarct size in rat isolated heart (2002) (1)
Ischaemic preconditioning may abolish the protection afforded by preoperative nicorandil in isolated human atrial muscle (1996) (1)
Delayed ischemic preconditioning of pig myocardium (1999) (1)
Remote ischaemic preconditioning confers cardioprotection over and above cardioplegia during cardiac surgery (2008) (1)
A model of hypoxic preconditioning in adult rabbit cardiac myocytes in culture (1998) (1)
GLP-1 protects ischemic and reperfused myocardium via PI3kinase and p42/p44 MAPK signalling pathways (2004) (1)
An investigation into the effects of simulated ischaemic preconditioning on mitochondrial fusion in mouse embryonic fibroblasts (2015) (1)
Cardiovascular outcomes associated with treatment of type 2 diabetes in patients with ischaemic heart failure (2022) (1)
ISCHEMIC PRECONDITIONING OF THE RAT MYOCARDIUM OCCURS VIA A PROTEIN-KINASE C-DEPENDENT PATHWAY (1994) (1)
Myosin light chain phosphorylation during regional myocardial ischemia. (1983) (1)
107 Remote ischaemic preconditioning and human atrial trabeculae in the diabetic heart (2012) (1)
310Plasma exosomes from rats and humans protect the myocardium from ischemia-reperfusion injury (2014) (1)
Inability of chronic chemical sympathectomy to induce coronary collateral growth or development: studies in the rat heart in vivo. (1989) (1)
Atorvastatin reduces infarct size in an isolated rat heart model by activating pro-survival kinases (2006) (1)
224 Stromal Derived Factor 1 Alpha is a Mediator of Conditioning in Human and Rat Myocardium (2014) (1)
CMR detects a reduction in infarct size and myocardial edema when primary PCI is augmented by Remote Ischemic Conditioning. A randomized trial (2014) (1)
Failure of metoprolol to limit myocardial infarct size during 24 hours of coronary artery occlusion in a closed chest dog (1984) (1)
DELAYED-EFFECTS OF THE ENDOTOXIN DERIVATIVE, MONOPHOSPHORYL LIPID-A, ON RESPONSES TO ISCHEMIA-REPERFUSION IN RABBIT MYOCARDIUM (1995) (1)
Down-regulation of miR-24 in diabetes: a novel insight into the mechanism of diabetic exacerbation of myocardial ischaemia-reperfusion injury (2020) (1)
The human diabetic myocardium has a higher threshold for protection against simulated ischaemia–reperfusion injury (2008) (1)
Omapatrilat, a vasopeptidase inhibitor, lowers the threshold for induction of ischaemic preconditioning through a bradykinin-mediated mechanism (2001) (1)
HYPOXIC PRECONDITIONING OF HUMAN RIGHT ATRIAL TRABECULA INVOLVES A PROTEIN KINASE-C-DEPENDENT MECHANISM (1995) (1)
Predicting peri-procedural myocardial infarction during PCI (2012) (1)
Abstract 609: Erythropoietin-Mediated Protection Against Hypoxia/Reoxygenation Injury in Human Muscle is via Phosphatidylinositol-3-Kinase and P42/44 Kinase Activation (2006) (1)
Molecular mechanisms of preconditioning: therapeutic implications. (1998) (1)
Ischaemic Preconditioning Reduces Myocardial Injury in Patients Undergoing Cardiac Surgery (1996) (1)
Fasting increases susceptibility to acute myocardial ischaemia/reperfusion injury through a sirtuin-3 mediated increase in fatty acid oxidation (2022) (1)
Delayed preconditioning and diazoxide-mediated cytoprotection occur independently of a change in mitochondrial membrane potential in a human cardiac cell line (2000) (1)
P163Stromal derived factor 1-a protects human heart tissue from simulated ischaemia-reperfusion injury (2014) (1)
MITOCHONDRIAL FUSION BY GENETIC OR PHARMACOLOGICAL MANIPULATION PROTECTS AGAINST ISCHAEMIA-REPERFUSION INJURY (2009) (1)
Reperfusion induced injury attenuated by atorvastatin in an experimental model of myocardial ischaemia/reperfusion: a role for p44/42 mapkinase and PI3kinase (2004) (1)
Corrigendum to 'Conditioning' the heart during surgery (2009) (1)
Quantifying the area-at-risk of myocardial infarction in-vivo using arterial spin labeling cardiac magnetic resonance (2017) (1)
Rapid atrial pacing fails to precondition the rabbit heart (1992) (1)
Factors influencing infarct size: Is coronary collateral flow the key determinant? (1986) (1)
POSSIBLE INVOLVEMENT OF PROTEIN-KINASE-C SIGNALING IN THE 2ND WINDOW OF PROTECTION FOLLOWING ISCHEMIC PRECONDITIONING (1994) (1)
Cardioprotective actions of necrostatin (2007) (0)
Remote ischaemic preconditioning - Reply (2007) (0)
Lack of spontaneous or verapamil-induced salvage of potentially necrotic myocardium following 24 hours of coronary artery occlusion in the rabbit (1986) (0)
EFFECT OF ADENOSINE RECEPTOR BLOCKADE DURING ISCHEMIC PRECONDITIONING ON A 2ND WINDOW OF PROTECTION IN RABBIT MYOCARDIUM (1994) (0)
20 Investigating sodium-glucose co-transporter 1 (SGLT1) in myocardium and its role in hyperglycemia ischaemia-reperfusion injury (2020) (0)
253 REMOTE ISCHAEMIC PRECONDITIONING IS MEDIATED VIA THE SDF 1Α/CXCR4 SIGNALLING AXIS (2013) (0)
Silencing PTEN, a negative regulator of the PI3K/AKT pathway, is not sufficient to confer protection against simulated ischaemia and reperfusion (2008) (0)
Atorvastatin, Administered at the Onset of Reperfusion, Protects Human Myocardium Against Lethal Reperfusion Injury by Activation of the RISK pathway (2011) (0)
REVERSAL OF LEFT VENTRICULAR HYPERTROPHY : EXTENDING THE AIMS OF ANTIHYPERTENSIVE THERAPY (1993) (0)
Slow, spontaneous calcium waves occur during reperfusion after cardiac ischaemia, and precede opening of the mitochondrial permeability transition pore. (2010) (0)
Myocardial preconditioning - experimental and clinical perspectives (2001) (0)
Does the mitochondrial permeability transition pore have a role in preconditioning?-letter to editor (2004) (0)
The rat: An unsuitable model for the assessment of the pharmacological limitation of infarct size? (1986) (0)
Ischaemic preconditioning decreases the level of p53 via MDM2 phosphorylation in an isolated rat heart model (2003) (0)
30 Endothelial dysfunction and/or impaired vascular insulin signalling may have a role in ischaemic preconditioning (2011) (0)
P495Investigating SDF-1alpha signalling via CXCR7 receptor in the endothelium (2018) (0)
Effect of Remote Ischemic Preconditioning on Clinical Outcomes in Patient Undergoing Coronary Artery Bypass Graft Surgery trial involving adult patients undergoing coronary artery bypass graft. Postoperative AKI within 72 hours was defined using the International Kidney Disease: Improving Global Out (2018) (0)
Bradykinin limits ischemia/reperfusion injury when administered at reperfusion via a PI3K and nitric oxide dependent pathway. A study in eNOS knockout mice. (2001) (0)
The Relationship between The KATP Channel and Myocardial Preconditioning (1995) (0)
018 The interaction between the humoural and neural pathways underlying remote ischaemic preconditioning (2010) (0)
CYCLOPHILIN-D ABLATION OFFERS LONG-TERM PROTECTION AGAINST ACUTE MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY (2011) (0)
225 T2-MAPPING CARDIAC MAGNETIC RESONANCE IMAGING FOR ASSESSING AREA-AT-RISK IN A MURINE MODEL OF MYOCARDIAL ISCHAEMIA-REPERFUSION INJURY (2013) (0)
Phenotypic changes in low-density lipoprotein particles as markers of adverse clinical outcomes in COVID-19 (2023) (0)
Neither heat stress nor ischaemic preconditioning alter myocardial mRNA expression of the ATP-sensitive potassium subunit Kir 6.2 (1999) (0)
Remote ischaemic preconditioning – Authors' reply (2007) (0)
Chapter 5 Coronary No-Reflow and Microvascular Obstruction (2009) (0)
Three states of evolving myocardial ischaemic injury (1983) (0)
Glucagon-like peptide-1 (GLP-1) receptor activation dilates cerebral arterioles, increases cerebral blood flow, and mediates remote (pre)conditioning neuroprotection against ischaemic stroke. (2021) (0)
Anti-ischaemic action of transforming growth factor beta-1 in the rat isolated heart is abolished by the p38 MAPK inhibitor SB203580 (1998) (0)
Ischemic Preconditioning (Developments in Cardiovascular Medicine) (1994) (0)
Transient activation of adenosine A 1 receptors induces delayed cardioprotection in rats: role for Mn-superoxide dismutase (1999) (0)
Acute treatment with statins not chronic treatment attenuates infarct in an isolated rat heart model (2004) (0)
Remote Ischaemic Conditioning in Carotid Artery Stenting: Another Step on the Journey Toward Clinical Translatability? (2017) (0)
Preconditioning in Human Muscle and Myocytes (1997) (0)
PI3 kinase and not P42/P44 map kinase appears to be implicated in the protection conferred by ischemic precondtitoning (2002) (0)
THE DIFFERENTIAL EFFECTS OF SIRTUIN-3 IN CARDIO-PROTECTION (2014) (0)
Cardiovascular management and the prevention of cognitive decline (2005) (0)
Beyond Glucose Control (2008) (0)
Late adaptive responses to sublethal ischaemia: a second window of protection after ischaemic preconditioning (1997) (0)
Pharmacological approaches to infarct size limitation (1986) (0)
246 CHARACTERISATION OF ILOMASTAT-MEDIATED PROTECTION (2013) (0)
Troponin trends during anthracycline chemotherapy and their correlation with cardiovascular risk scores (2020) (0)
Ischaemic preconditioning - an option for therapy (1997) (0)
Dose dependent cardioprotective properties of nitric oxide donors are concomitant with changes in mitochondrial membrane potential. (2001) (0)
THE APPLICATION OF RISK ZONE ANALYSIS TO THE STUDY OF INFARCT SIZE LIMITATION IN THE CLOSED-CHEST DOG WITH CORONARY-ARTERY EMBOLIZATION (1983) (0)
The role of stress proteins in myocardial protection (1992) (0)
Protein KinaseC ItsRoleinIschemic Preconditioning intheRat (1994) (0)
038 Detrimental effects of erythropoietin as an adjunct to PPCI: a randomised controlled trial in acute MI using cardiac MRI (2010) (0)
BAS/BSCR21 Akt protects the heart by promoting mitochondrial fusion (2010) (0)
The Retrogradely Perfused Isolated Heart Model (2006) (0)
Editors' network of the European Society of Cardiology National Cardiovascular Journals: Scientific input from the National Societies (2015) (0)
Poster session 3 (2001) (0)
Inhibition of protein phosphatase 2B by cyclosporin-A limits infarct size in the isolated rat heart (1997) (0)
Protecting the heart at the time of reperfusion: The role of insulin and glucagon-like peptide-1 (2005) (0)
Potential cardioprotective role of insulin at reperfusion by a possible anti-apoptotic mechanism (1999) (0)
Salvage of ischemic myocardium by allopurinol: Importance of pre-treatment (1987) (0)
Matrix Metalloproteinase inhibition is cardioprotective against reperfusion injury by a mechanism that is both independent and additive to mitochondrial permeability transition pore inhibition (2012) (0)
The cardioprotective kinase, Akt, modulates mitochondrial dynamics (2007) (0)
ST-I-4 Preconditioning and nicorandil for treatment of ischaemic heart disease (2002) (0)
Apoptosis, A Double-Edge Sword! (2017) (0)
Quantification of ischaemic stimulus required to elicit the second window of protection against infarction in the rabbit (1996) (0)
Recruiting to time and target: experiences from the ERIC-PPCI trial (2019) (0)
Atorvastatin limits repertusion injury via activation of PI3K and eNOS (2002) (0)
BAS/BSCR32 Nicotinic acid adenine nucleotide phosphate is involved in ischaemia-reperfusion-induced ca2+ oscillations and cell death (2010) (0)
Pharmacological cardioprotection in diabetes (2015) (0)
AMPK activation at reperfusion: A novel cardioprotective target? (2007) (0)
Myocardial protection via A3 adenosine receptors is mediated via PI3-kinase and P42/44 dependent pathways (2004) (0)
Brief coronary artery occlusions by intracoronary balloon inflation induce delayed preconditioning against infarction in pig myocardium. (1998) (0)
THE ROLE OF STRESS PROTEINS IN MYOCARDIAL ADAPTATION TO INJURY (1994) (0)
The effect of erythropoietin as an adjunct to PPCI: a randomised controlled trial (2010) (0)
Transforming growth factor á1protects the ischaemic and reperfused myocardium through p38 MAP kinase signalling pathway (1998) (0)
Nicorandil, a K-ATP channel opener causes mitochondrial membrane depolarisation which is inhibited by the sulphonylurea glibenclamide but not by the sulphonylurea glimepiride. (2001) (0)
Abstract 20665: Cardiac Arterial Spin Labeling MRI as a Novel Approach for in vivo Quantification of the Area-At-Risk (2014) (0)
Characterisation and validation of a new murine model of ischemia-reperfusion injury (1996) (0)
VERAPAMIL LIMITS INFARCT SIZE 24 HOURS FOLLOWING CORONARY EMBOLIZATION IN THE DOG (1983) (0)
Apelin a vasoactive adipocytokine, exhibits direct cardioprotective effects (2006) (0)
Does Not Prevent Insulin Transport Across the Endothelium in a Mouse Langendorff Model Reperfusion Injury But − Endothelial Insulin Resistance Protects the Heart Against Prolonged Ischemia (2014) (0)
SGLT2 inhibitor, Canagliflozin, attenuates myocardial infarction in the diabetic and non-diabetic heart Short title: SGL2 inhibition attenuates myocardial infarction (2018) (0)
Adenosine and Delayed Cardioprotection (1998) (0)
Inadvertent preconditioning - Is it inevitable? (1997) (0)
116 Matrix metalloproteinase inhibition attenuates reperfusion injury, independently of and additive to mitochondrial permeability transition pore inhibition (2012) (0)
A novel antibody specific to full-length stromal derived factor-1 alpha reveals that remote conditioning induces its cleavage by endothelial dipeptidyl peptidase 4 (2016) (0)
Conditioning' the heart during surgery (vol 35, pg 977, 2009) (2009) (0)
Trial Designs Effect of Remote Ischaemic Conditioning in Oncology Patients Undergoing Chemotherapy : Rationale and Design of the ERIC-ONC Study — A Single-Center , Blinded , Randomized Controlled Trial (2016) (0)
Reperfusion injury: the importance of prosurvival signalling (2004) (0)
Rimonabant protects against myocardial ischemia–reperfusion injury in vivo (2008) (0)
320 Preconditioning protects via dual modulation of the mitochondrial permeability transition pore (2003) (0)
CARDIAC ARTERIAL SPIN LABELLING MRI AS A NOVEL APPROACH FOR IN VIVO QUANTIFICATION OF THE AREA-AT-RISK (2014) (0)
013 Modulating mitochondrial dynamics as a novel cardioprotective strategy (2010) (0)
T1 High glucose and myocardial ischaemia/reperfusion injury: the role of the sodium/glucose transporter, SGLT1 (2016) (0)
The Mitochondrial Permeability Transition Pore is a Target for Pharmacological Cardioprotection in Human Hypertrophic Cardiomyopathy (2011) (0)
Mitochondrial KATP channel activation protects the myocyte against oxidative stress by inhibiting mitochondrial permeability transition pore opening (2002) (0)
VERAPAMIL LIMITS MYOCARDIAL NECROSIS ONLY IN THE PRESENCE OF SIGNIFICANT CORONARY COLLATERAL FLOW (1986) (0)
IL-3 Reperfusion injury revisited:- The role of cell survivall signalling (2002) (0)
Inhibition of nuclear factor kappa-B does not modify early myocardial reperfusion injury (2002) (0)
Reply to Dr. Edward J. Lesnefsky (1993) (0)
Opioids in Acute Coronary Syndromes: Friend or Foe? (2022) (0)
BAS/BSCR34 Is an increased AMPK activation during ischaemia essential for the protection of the heart against infarction? (2010) (0)
ADENOSINE-DEPENDENT MYOCARDIAL PROTECTION FOLLOWING NITRIC-OXIDE INHIBITION IS NOT THE RESULT OF MYOCARDIAL-ISCHEMIA (1994) (0)
Preconditioning in the Heart (2013) (0)
P445The differential effects of Sirtuin-3 in cardio-protection (2014) (0)
Failure to ischaemic postcondition the diabetic heart (2006) (0)
Preconditioning and postconditioning : from bench to bedside : ischaemic conditioning (2009) (0)
Pretreatment with a Nitric Oxide Inhibitor Reduces Infarct size in both the in vivo and the in vitro Rabbit Heart (1993) (0)
39 Endogenous protection against myocardial ischaemia-reperfusion injury in the diabetic heart (2011) (0)
The mitochondrial permeability transition pore as a critical determinant of cell death (2005) (0)
Chapter 1 An Introduction to Cardioprotection (2009) (0)
Preconditioning and postconditioning: The essential role of the mitochondrial permeability transition pore (2007) (0)
Transforming growth factor-β1 limits infarct size when administered prior to reperfusion in the rat isolated heart (1999) (0)
The authors reply [17] (2007) (0)
Stabilisation of hypoxia inducible factor at reperfusion protects human atrial trabeculae against ischaemia-reperfusion injury (2012) (0)
Activated nuclear factor kappa-B does not mediate early reperfusion injury (2002) (0)
The adipocytokine, resistin, is not cardioprotective despite activating components of the risk pathway (2008) (0)
Delayed myocardial protection following exercise appears to involve protein kinase C pathway in rat heart. (1998) (0)
Over-expression of the cardioprotective kinase Akt modulates mitochondrial morphology (2008) (0)
The Mechanism of Cardiac Protection Following Sublethal Ischemia and Sublethal Heat-Stress (1994) (0)
PROTECTION BY PRECONDITIONING IS INDEPENDENT OF ARTERIAL PERFUSION (1993) (0)
Ischaemic preconditioning ofmyocardium: a new paradigm forclinical cardioprotection ? (1994) (0)
M itochondrial K channels : role in cardioprotectionATP (2002) (0)
Heat Shock Proteins and the Cardiovascular System (1997) (0)
Chapter 11 Novel Cardioprotective Strategies (2009) (0)
Failure of heat shock (HS) response to limit tissue necrosis in the rabbit heart (1991) (0)
Does combination therapy with allopurinol and verapamil limit infarct size in dogs (1986) (0)
Transforming growth factor-β1 limits infarction when administered during early reperfusion: modification of lethal reperfusion injury? (1999) (0)
Temporal and transmural characteristics of collateral flow as a determinant of metabolism and injury during evolving myocardial infarction (1986) (0)
Glucagon-like peptide-1 (GLP-1), a gut incretin, protects the myocardium against ischemic/reperfusion injury through the myocardial GLP-1 receptor and activation of prosurvival pathways (2004) (0)
9 Importance of intrinsic cardiac nerves in both direct and remote ischaemic conditioning (2015) (0)
CHANGES IN BLOOD-FLOW TO ISCHEMIC MYOCARDIUM IN THE 24 HOURS AFTER CORONARY-ARTERY OCCLUSION IN THE DOG (1988) (0)
basic mechanisms to clinical applications in heart protection, new players in cardiovascular diseases and cardiac theranostics: meeting frontiers in cardiovascular 69-81. (2016) (0)
Untreated HIV: harmful even at high CD4 cell counts (2010) (0)
Investigating sodium-glucose co-transporters 1 (SGLT1) in myocardium and its role in hyperglycaemia ischaemia-reperfusion injury (2020) (0)
Prolonging the delayed phase of myocardial protection: anti-infarct effects of adenosine A1 receptor activation are maintained despite repetitive dosing (1997) (0)
Transient limb ischaemia reduces myocardial injury in patients undergoing cardiac surgery using cardioplegia: a randomised controlled study (2008) (0)
The cardioprotective effect of inhibiting SGLT1 in hyperglycemia ischemia reperfusion injury (2022) (0)
The pathophysiology of myocardial protection (1994) (0)
Abstract P752: Neuroprotection by Remote Ischemic Conditioning in the Setting of Acute Ischemic Stroke: A Preclinical Two-Centre International Study (2021) (0)
The resistance of rabbit papillary muscle to high flow hypoxia is enhanced by heat stress when pyruvate is used as substrate (1992) (0)
Pten haploinsufficiency is not able to protect the myocardium against ischaemia reperfusion injury (2007) (0)
Renal preconditioning of the myocardium involves KATP channels and adenosine receptors (1998) (0)
Book review (2004) (0)
Mitochondrial DJ-1 as a target for cardioprotection (2012) (0)
Cardioprotective properties of matrix metalloproteinase inhibition: attenuation of nuclear protease activity, reduced DNA fragmentation and preserved OGG1 (2015) (0)
Definition of the epicardial “borderzone” in acute myocardial infarction (1979) (0)
Preconditioning via Mitochondrial KATP Channel Activation Protects Cardiomyocytes from Oxidative Stress by Inhibiting Mitochondrial Permeability Transition Pore Opening (2003) (0)
INHIBITION OF NITRIC-OXIDE REDUCES INFARCT SIZE IN THE RABBIT ISOLATED HEART THROUGH ADENOSINE RELEASE (1994) (0)
Investigation into the role of mavacamten in myocardial ischaemia-reperfusion injury (2022) (0)
16 Matrix metalloproteinase inhibition is a parallel pathway to protection against reperfusion injury, both independent and additive to mitochondrial permeability transition pore inhibition (2011) (0)
QUANTIFICATION OF RISK ZONE AFTER CORONARY-OCCLUSION IN THE RAT USING AUTORADIOGRAPHIC METHODS - EFFECT OF A XANTHINE-OXIDASE INHIBITOR, ALLOPURINOL (1985) (0)
Remote ischemic preconditioning using transient arm ischemia reduces myocardial injury during cardiac surgery (2007) (0)
Workshop : Cardioprotection – from novel targets to clinical application (2016) (0)
Urocortin (UCN) protects the heart from reperfusion injury via activation of the p42/44 mitogen activated protein kinase (MAPK) pathway: A possible reperfusion injury salvage kinase (RISK) (2001) (0)
HIGH-DOSE ORAL ATORVASTATIN PRETREATMENT OF PATIENTS UNDERGOING CARDIAC SURGERY PROTECTS ATRIAL MUSCLE AGAINST SIMULATED ISCHAEMIA-REPERFUSION INJURY (2009) (0)
BS10 Canagliflozin, an SGLT2 inhibitor attenuates ischaemia/reperfusion injury in the non-diabetic heart (2019) (0)
015 Mitochondrial cyclophilin-D as a therapeutic target for post-myocardial infarction heart failure (2010) (0)
Delayed adenosine induced pharmacological preconditioning: involvement of protein kinases and Mn-superoxide dismutase (1998) (0)
193 The role of the pi3k-alpha isoform in cardioprotection (2017) (0)
P645T2-mapping cardiac MRI for in vivo quantification of myocardial area-at-risk (2014) (0)
cardioprotection in the human heart Mitochondrial permeability transition pore as a target for (2016) (0)
Editorial Cardiovascular & Renal: Ischaemic preconditioning: rational basis for drug design (1996) (0)
Metformin protects against myocardial reperfusion injury via PI3-kinase-dependent inhibition of mitochondrial permeability transition (2006) (0)
AMP579, an adenosine A(1) and A(2A) receptor agonist, limits infarct size in rabbit heart in vivo when given at reperfusion: Role of A(2A) receptor activation (2001) (0)
Metformin protects against myocardial infarction independent of its glucose lowering effects (2008) (0)
MITOCHONDRIAL TRANSITION PORE AND PRECONDITIONING 1 PRECONDITIONING PROTECTS BY INHIBITING THE MITOCHONDRIAL PERMEABILITY TRANSITION (2004) (0)
4984 Multi-parametric MRI assessment of myocardial ischemia-reperfusion injury in mice (2013) (0)
Heat-Stress Abates Free-Radical Generation in the Isolated Reperfused Rat-Heart (1992) (0)
Symbols and abbreviations (2009) (0)
THE DISCOVERY OF ISCHAEMIC PRECONDITIONING. AUTHOR'S REPLIES (1993) (0)
BAS/BSCR45 The mitochondrial permeability transition pore as a target for cardioprotection in ventricular cardiomyocytes harvested from patients with obstructive hypertrophic cardiomyopathy (2010) (0)
SP188EFFECT OF REMOTE ISCHEMIC PRECONDITIONING ON AKI INCIDENCE AND OUTCOMES FOLLOWING CARDIAC SURGERY: RESULTS OF A MULTI-CENTRE RANDOMISED CONTROLLED TRIAL (2015) (0)
Attenuation of myocardial injury 24 hours after administration of a diacylglycerol analogue in vivo (1997) (0)
Nicorandil — an Effective Multitarget Drug for Cardioprotection? (2022) (0)
Hyperglycemic exacerbation of myocardial infarction through SGLT1 - a glucose paradox. (2023) (0)
BAS/BSCR33 Cardioprotection by hypoxia-inducible factor-1α: underlying beneficial effects on mitochondrial function (2010) (0)
Abstract 220: The Cardioprotective Kinase, Akt, Modulates Mitochondrial Dynamics (2007) (0)
Cardio-oncology Issues in Lymphoma Patients. (2022) (0)
Occurrence of apoptosis in specific cell types in isolated perfused rat hearts exposed to ischaemia and reperfusion (1999) (0)
2 Indicators of perioperative myocardial injury and infarction in cardiac surgery (2012) (0)
Correction to: RIC in COVID-19—a Clinical Trial to Investigate Whether Remote Ischemic Conditioning (RIC) Can Prevent Deterioration to Critical Care in Patients with COVID-19 (2021) (0)
THE MITOCHONDRIAL PERMEABILITY TRANSITION PORE AS A MEDIATOR OF ISCHAEMIC PRECONDITIONING (2009) (0)
Reply to "Circadian variation in acute myocardial infarction size: Likely involvement of the melatonin and suprachiasmatic nuclei". (2017) (0)
Does the mitochondrial permeability transition have a role in preconditioning? Response (2004) (0)
CHARACTERISING A NOVEL ANTIBODY FOR FULL-LENGTH (ACTIVE) STROMAL DERIVED FACTOR-1α (1–67) (2014) (0)
Clinical translation of cardioprotective (2008) (0)
Pioneer in Cardiology: Derek Yellon, PhD, DSc, FRCP(Hon), FACC, FESC, FAHA "I Enjoy What I Do So Much Because It Stretches From Cell Biology and Complex Molecular Biology to Patient Care" (2010) (0)
Characterization of the Lateral lschemic Tissue in the Canine Evolving Myocardial Infarction (1981) (0)
HEARTJNL223867 1560..1565 (0)
Erythropoietin doubles the incidence of microvascular obstruction in primary PCI - a randomized controlled trial in acute MI using CMR primary endpoints (2010) (0)
Failure of dimethylthiourea to limit myocardial tissue necrosis in rabbits during ischemia and reperfusion (1988) (0)
High-sensitivity Troponin-T levels in reperfused STEMI patients: A comparison with CMR (2016) (0)
Reply to Landoni et al. (2010) (0)
Postconditioning in the Mouse Glycogen Synthase Kinase-3 Inactivation Is Not Required for Ischemic Preconditioning or (2008) (0)
Leptin-induced cardioprotection is dependent on the presence of functional OB-Rb receptors (2007) (0)
Transient upper arm ischemia reduces myocardial injury in patients undergoing cardiac bypass surgery (2007) (0)
100 Role of PI3kinase and p70S6kinase activation in delayed preconditioning (2003) (0)
Therapeutic infarct size reduction (1984) (0)
Endothelial cells release cardioprotective exosomes that may contribute to ischaemic preconditioning (2018) (0)
Preconditioning in human cardiac muscle is potentiated by ACE inhibition via a B2 bradykinin receptor pathway (1996) (0)
Cardioprotection from ischaemia-reperfusion injury: Dissecting the PI3K/AKT pathway with chemical inhibition of PTEN (2008) (0)
Preconditioning and postconditioning: from bench to bedside (2017) (0)
SUBLETHAL THERMAL AND ISCHEMIC STRESSES INDUCE STRESS PROTEINS AND INCREASE RESISTANCE TO SUBSEQUENT INFARCTION (1993) (0)
MULTIPLE BIOPSY GUN FOR THE STUDY OF 3-DIMENSIONAL METABOLIC GEOMETRY (1979) (0)
missing link'' Letter to the editor: ''Zinc and cardioprotection: the (2013) (0)
Ischernic preconditioning and Mdm2 phosphorylation: Possible protection via p53 down-regulation (2003) (0)
P653Efficacy of remote ischaemic preconditioning in diabetic rats (2014) (0)
28 Remote ischaemic conditioning involves signalling via CXCR4 but does not increase circulating levels of its known ligands (2015) (0)
Adenosine-induced increases in myocardial ATP content do not improve resistance to ischemia in the isolated rat heart (1987) (0)
Myocardial ischaemic tolerance following heat stress is abolished by KATP channel blockade (1997) (0)
The rate of progression of myocardial necrosis in the rabbit withischaemia and reperfusion (1987) (0)
229 THE IMPAIRMENT OF INNATE CARDIOPROTECTIVE SIGNALING IN THE AGED, DIABETIC RAT HEART (2013) (0)
BAS/BSCR44 Akt isoforms in ischaemic preconditioning (2010) (0)
57 The effect of remote ischemic conditioning and glyceryl trinitrate on perioperative myocardial injury in cardiac bypass surgery patients: the eric-gtn study (2017) (0)
APPARENT PROTECTION AFFORDED BY ALLOPURINOL IN THE 1ST 24 HOURS OF PERMANENT CORONARY-OCCLUSION IS DIMINISHED AFTER 48 HOURS (1987) (0)
CONFERENCE Cardiac preconditioning (1994) (0)
Cyclophilin-D ablation offers long-term protection against lethal myocardial reperfusion injury (2012) (0)
The delta and epsilon isoforms of protein kinase C have opposing actions in human atrial muscle during simulated ischaemia-reperfusion injury (2008) (0)
Erythropoetin protects the myocardium from reperfusion injury (2004) (0)
The adipocytokine, visfatin, reduces myocardial infarct size, when given at time of reperfusion, by inhibiting the mitochondrial permeability transition pore (2007) (0)
Protein kinase C delta and epsilon isoforms have divergent roles in simulated ischaemia–reperfusion injury in human atrial muscle (2008) (0)
Poster Session 3 (2012) (0)
PROTECTION AGAINST ISCHEMIC-INJURY IN RABBIT MYOCARDIUM 24 HOURS AFTER ADENOSINE A(1) RECEPTOR ACTIVATION (1994) (0)
The importance of the reperfusion phase in ischaemic preconditioning (2004) (0)
Anthracyclines and Biomarkers of Myocardial Injury (2023) (0)
Uncoupling of mitochondrial oxidative phosphorylation preconditions the isolated rat heart (1999) (0)
Protecting the diabetic ischemic heart (2007) (0)
Infarct-limiting action of transforming growth factor beta 1 in isolated rat heart is abolished by the p38 MAPK inhibitor SB203580 (1998) (0)
Erythropoietin reduces caspase 3 activation in the human atrial muscle undegoing hypoxia/reoxygenation injury (2007) (0)
Temporal, transmural and lateral characteristics of flow interfaces in the porcine heart during regional myocardial ischemia (1984) (0)
Heat stress and myocardial protection (1999) (0)
Professor Lionel H. Opie 6th May 1933-20th February 2020. (2020) (0)
The Cytokine Storm of COVID-19; Focus on Prevention and Protection (2020) (0)
Leptin-stimulated inhibition of mitochondrial permeability transition is dependent on presence of functional OB-RB leptin receptor (2008) (0)
The effect of preconditioning (Ischemic and pharmacological), cross-clamp fibrillation and cold cardioplegia on myocardial necrosis during CABG (1999) (0)
36 Cyclophilin-D ablation offers long-term protection against acute myocardial ischaemia-reperfusion injury (2011) (0)
P420NAADP signalling augments ischaemia-reperfusion injury via two-pore channel 1 (TPC1) (2014) (0)
BAS/BSCR15 The role of PINK1, a mitochondrial pro-survival kinase, in myocardial ischaemia-reperfusion (2010) (0)
Rho-kinase mediates reoxygenation-induced cardiomyocyte death and promotes mitochondrial transition pore opening (2008) (0)
'Conditioning' the heart (2007) (0)
Is the infarct-limiting effect of nicorandil modified by ischaemic preconditioning? (1997) (0)
Short-term pre-treatment with atorvastatin reduces infarct size in an isolated rat heart model of ischaemia/reperfusion injury (2004) (0)
Atorvastatin reduces infarct size acutely in an isolated rat heart model (2004) (0)
The role of parasympathetic mechanisms in the infarct-limiting effect of SGLT2 inhibitor ertugliflozin (2021) (0)
PI3K but not ERK appears to be implicated in the protection conferred by ischemic preconditioning in the isolated rat heart (2001) (0)
P443Investigating coronary effluent transfer as a valid model of remote ischaemic conditioning: the role of stromal derived factor one alpha (SDF-1alpha) and nitric oxide (2014) (0)
Fish oils and cardioprotection: mechanisms explored (2002) (0)
Do heat shock proteins play a role in preconditioning (1997) (0)
Glycolytic enzyme gene expression during the development of hypoxia-induced cardiac hypertrophy. (1998) (0)
Type-B natriuretic peptide limits infarct size via KATP channel opening (2002) (0)
Human atrial trabeculae superfused with human serum are resistant to the acute effects of exposure to Fe3 (1992) (0)
The Power Of Drug Co-Administration: Smaller Doses Better Outcomes (2007) (0)
P13 kinase and not P42/P44 map kinase appears to be implicated in the protection conferred by ischemic preconditioning (2002) (0)
P437Beta3-adrenergic receptor stimulation reduces ischemia/reperfusion injury through inhibition of the mitochondrial transition pore opening (mPTP) and subsequent apoptotic inhibition (2014) (0)
Erythropoietin protects against ischaemia–reperfusion injury in the human muscle via PI3-kinase activation (2006) (0)
Infarct Size Limitation: Principles and Problems (1986) (0)
Abstract 2274: Remote Ischemic Preconditioning Using Transient Arm Ischemia Reduces Myocardial Injury During Cardiac Surgery (2007) (0)
Preconditioning and postconditioning: The mitochondrial permeablity transition pore as the common end-effector (2007) (0)

This paper list is powered by the following services:

Other Resources About Derek M. Yellon

What Schools Are Affiliated With Derek M. Yellon?

Derek M. Yellon is affiliated with the following schools:

Derek M. Yellon's Academic­Influence.com Rankings